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ABSTRACT
Inflammation and Altered Signaling in Obstetric Pathologies
Ya-Fang Tsai
Department of Physiology and Developmental Biology, BYU
Doctor of Philosophy
The purpose of this research project was to elucidate the molecular interactions and detail
the signaling pathways in obstetric pathologies. This work first seeks to understand inflammation
related complications relevant to obstetrics. Prior research in our lab identified the implications
of the receptor of advanced glycation end products (RAGE) during inflammatory response in the
placenta. Current work identified the presence of DNA double-strand breaks (DNA-DSBs) in
inflammation associated pregnancy complications of preeclampsia (PE) and preterm labor (PTL)
and demonstrated the positive role of RAGE in repairing the damage.
The confluent relevance of disrupted mitochondrial function and inflammation has been
recognized in the etiology of numerous chronic diseases. Our current studies aim to understand
the connections between energy metabolism and inflammation in pathologies of pregnancy
complications. Previous research conducted in our laboratory has demonstrated the mediation of
the Gas6/Axl pathway on the mechanistic target of rapamycin (mTOR), an important metabolic
molecule. We observed the negative regulation of Gas6 treatment on the mTOR pathway and its
negative effects on trophoblast cell invasion. In the current study looking at the aspect of energy
regulation, we identified the activation of placental mTOR in gestational diabetes mellitus
(GDM) and its decrease during PE and intrauterine growth restriction (IUGR). We further
evaluated the regulation of mTOR on its downstream effector pyruvate kinase M2 (PKM2). We
found that inhibition of mTOR decreased PKM2 activation; while PKM2 activation positively
regulated trophoblastic invasion and rescued negative effects observed in our second-hand
smoke IUGR murine model.
Our work has opened a new direction of placental research, especially in pregnancy
complications stemming from genomic instability. We also clarified details of mTOR and
PKM2 meditated metabolic signaling that are crucial for future investigation on the dynamic
metabolic regulation during pregnancy.

Keywords: RAGE, DNA-DSB, mTOR, PKM2, preeclampsia, preterm labor, intrauterine growth
restriction, gestational diabetes mellitus, placenta, pregnancy, trophoblast
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CHAPTER 1: Introduction
The importance of pathology research has been recognized in recent years. Knowledge of
pathological pathways bridges the gap between basic science and clinical applications and
underpins every aspect of patient care from prevention and diagnosis to treatment options and
post-treatment care (Rodriguez-Canales et al., 2011; Sanfilippo, 2014). One of the major
successes in modern health science was the identification of the contributions of inflammation
and altered metabolism in disease developments. This discovery provides advanced knowledge
in disease prevention and makes many treatment options available (Osborn & Olefsky, 2012).
While most obstetric complications are linked to inflammatory and metabolic issues, their
pathological pathways remain largely unexplored (Challis et al., 2009; Do et al., 2019). Our
research primarily focuses on the inflammatory and metabolic signaling pathways during
pregnancy complications.
The Placenta
During gestation, appropriate communication between the mother and the fetus is
essential for a successful pregnancy. This connection is governed by the organ of the placenta.
The major functions of the placenta include nutrient delivery and barrier protection between the
mother and the fetus and are carried out by trophoblast cells (Turco & Moffett, 2019). The two
main trophoblast cell types that make up the placenta are syncytiotrophoblasts and
cytotrophoblasts. Syncytiotrophoblasts (SCT) are specialized epithelial cells that provide
immune protection in direct contact with the maternal side. In the intervillous space, SCT
becomes the outer lining of placental villi and allows maternal and fetal nutrient and waste
exchange. The invasive cytotrophoblasts invade the endometrium and myometrium, remodeling
spiral arteries from high to low resistance vasculature for larger oxygen and nutrient delivery
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(Knöfler et al., 2019). Thus, the survival and functions of trophoblast cells are critical in
maintaining a healthy placenta and allowing proper adaptation as pregnancy progresses (Maltepe
& Fisher, 2015).
Pregnancy Complications
Pregnancy complications are issues that arise during gestation which complicate maternal
and fetal health. A healthy placenta is critical to protect fetuses from maternal immune attack and
allow appropriate nutrient and waste exchange. Expectedly, most obstetric complications share
the common feature of a pathological placenta (Brosens et al., 2011; Fisher, 2000).
Preeclampsia (PE)
Preeclampsia complicates 2-8% of pregnancies globally (Espinoza et al., 2020). Though
the exact pathology remains unclear, advanced research reveals features of placental ischemia
and underdeveloped placenta as results for insufficient trophoblast invasion in preeclamptic
pregnancies. Clinical manifestations of PE include maternal hypertension, proteinuria, and signs
of liver and kidney damage. Depending on its severity, preeclampsia treatment usually focuses
on anti-hypertensive therapy, yet the only conclusive treatment is to remove the placenta.
Because of the need for placental removal, premature delivery often leaves lifelong effects on the
health and development of the infants (Rana et al., 2019).
Pre-term Labor (PTL)
Pre-term birth is defined as delivery before 37 weeks of gestation which occurs in 5-18%
of pregnancies worldwide. Current research suggests the immunopathogenesis theory, where
compromised immune adaptation causes the bidirectional inflammation in mother and fetus and
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results in the onset of delivery (Green & Arck, n.d.). Premature birth increases the risks of infant
mortality and disability later in life (Anderson & Cacola, 2017).
Intrauterine Growth Restriction (IUGR)
After preterm delivery, IUGR is the second leading cause of perinatal mortality and
morbidity (Nardozza et al., 2017). IUGR, as suggested by the name, is under desired fetal growth
in consequence of aberrant vasculature development and decreased vascular density in the
placental villi (Arroyo & Winn, 2008). This results in poor placental perfusion which alters fetal
nutrition leading to developmental adaptation that changes the physiology and metabolism of the
offspring (Guerby & Bujold, 2020).
Gestational Diabetes Mellitus (GDM)
Affecting 7-10% of pregnancies worldwide, GDM is when diabetes occurs during
pregnancy (Behboudi-Gandevani et al., 2019). Current treatments focus on metabolic control
through insulin or lifestyle/diet change (Desoye & Hauguel-De Mouzon, 2007). GDM is
characterized by an enlarged placenta and nutritional oversupply to the fetus. Excessive fetal
growth and increased risk of type 2 diabetes in the mother are often the results (Vince et al.,
2020).
Most pregnancy complications share the common feature of a pathological placenta as a
consequence of impaired trophoblast cell functions. Systemic inflammation and metabolic
imbalance are known to be deleterious to cell functions and have been linked to undesired
pregnancy outcomes. Thus, research on inflammatory and metabolic pathways in the placenta is
essential for advanced disease prevention and treatments.
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Receptor for Advanced Glycation End-Products
In the uterus, the extent of inflammation will determine the reception or rejection of the
semi-allogeneic fetus. Though some is required for uterine receptivity and parturition, excessive
inflammation is involved in the development of many pregnancy complications such as PE, PTL,
and IUGR (Negishi et al., 2020). Significantly, the pathologies in these complications have been
linked to the receptor for advanced glycation end-products (RAGE) –mediated inflammatory
signaling pathway (Alexander et al., 2016; Buhimschi et al., 2009; Lewis et al., 2017; Noguchi et
al., 2010).
RAGE is a member of the immunoglobulin superfamily, consisting of a cytosolic tail, a
single hydrophobic transmembrane domain, and an extracellular region. The extracellular region
contains two C-type and one V-type immunoglobulin domain, wherein the V-type domain allows
three-dimensional recognition rather than specific amino acid sequences (Chuah et al., 2013).
Thus, RAGE is often referred to as a pattern recognition receptor and harbors a group of ligands.
Besides binding to advanced glycation end products (AGEs), RAGE also binds with amyloid βpeptide, high mobility group box protein 1 (HMGB1), and S100. The ligand-receptor interaction
is a common cellular pathway in inducing inflammatory response which implicates disease
progression such as pulmonary diseases, cancers, type 2 diabetes, and pregnancy complications
(Alexander et al., 2016; Buhimschi et al., 2009; Lewis et al., 2017; Marie Schmidt et al., n.d.;
Noguchi et al., 2010; Tadesse et al., 2014).
Although RAGE primarily functions as a cell surface receptor, different isoforms of
RAGE have also been identified such as soluble RAGE (sRAGE) and nuclear RAGE (nRAGE)
(Kumar et al., 2017; Mulrennan et al., 2015). sRAGE corresponds to the extracellular region of
RAGE. Lacking transmembrane and cytosolic domains, sRAGE is produced either through
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alternative splicing or proteolytic processing of the membrane RAGE (Mulrennan et al., 2015).
Because of the conserved extracellular region, sRAGE shares the same ligand-binding specificity
and is able to alleviate inflammatory signaling by competitively preventing ligands from binding
to membrane RAGE (Koyama et al., 2007). This counteraction principle of sRAGE to membrane
receptor RAGE has been incorporated in RAGE-associated therapeutic target research by
utilizing RAGE neutralizing antibody and semi-synthetic glycosaminoglycan ethers (SAGEs)
(Strieder-Barboza et al., 2019; Tsai et al., 2019).
On the other hand, the nuclear isoform of RAGE was identified and shown to have a role
in DNA double-strand breaks (DNA-DSBs) repair in the lung tissue (Kumar et al., 2017). DNA
damage can be a part of the natural cell cycle. If left unrepaired, accumulative DNA defects can
induce tissue inflammation and disturb normal organ functions such as those reported in
preeclampsia (Shimizu et al., 2014; Tadesse et al., 2014). Therefore, identifying a placental DNA
repair pathway is critical in understanding disease progression and allows potential treatment
developments.
mTOR
mTOR is a member of the PI3k-assocaited kinase protein family and serves as a core
component of mTOR complex 1 and 2 (Sabatini, 2017). Functioning as the common downstream
effector of RAGE and AXL, mTOR regulates cell proliferation, survival and migration by
coordinating nutrients availability (Eva et al., 2020; Hirschi et al., 2019; Hou et al., 2014).
mTOR is expressed in placental trophoblast cells and mediates trophoblast proliferation,
placental growth, and nutrient transfer through the placental barriers from the mother to the fetus
(Jansson et al., 2012; Wen et al., 2005). mTOR is also a positive regulator of pyruvate kinase M2
(PKM2) (Sun et al., 2011). PKM2 catalyzes the last step of glycolysis and is responsible for ATP
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production under hypoxia condition (Vaupel & Harrison, 2004). mTOR has been shown to be
implicated during nutrient overload in GDM and oxidative stress in preeclampsia; in addition,
PKM2 is elevated during preeclampsia (Huang et al., 2020; Nguyen-Ngo et al., 2019). Thus, the
mTOR pathway and its effects on PKM2 are essential in understanding both physiological and
pathological placental and fetal developments.
Our work has identified the pathology of pregnancy complications stemming from
genomic instability and detailed the involvement of RAGE during placental DNA-DSBs repair.
We also described the effect of altered metabolic regulations on trophoblast functions in different
pregnancy complications. These findings offer a foundation for future research in the
investigation of DNA repair mechanisms in the placenta and metabolism-imbalance-associated
pathologies in obstetric complications.
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Abstract
Impaired DNA damage responses are associated with several diseases, including
pregnancy complications. Recent research identified an ATM-kinase dependent function for the
nuclear isoform of the receptor for advanced glycation end-products (RAGE) during double
strand break (DSB)-repair. RAGE contributes to end-resectioning of broken DNA sites by
binding with the MRE11-Rad50-Nbs1 (MRN) complex. Placental research is limited regarding
the impact of genomic instability and the mechanism for potential repair. We tested the
hypothesis regarding the involvement of RAGE during the repair of placental DNA-DSBs. We
first identified that the pregnancy complications of PE and preterm labor (PTL) experience loss
of genomic integrity and an in vitro trophoblast cell model was used to characterize trophoblast
DSBs. Colocalized immunofluorescence of ꝩ-H2AX and RAGE support the potential
involvement of RAGE in cellular responses to DNA-DSBs. Immunoblotting for both molecules
in PE and PTL placenta samples and in trophoblast cells validated a connection. Coimmunoprecipitation studies revealed interactions between RAGE and pATM and MRE11
during DNA-DSBs. Reduced cellular invasion confirmed the role of genomic instability in
trophoblastic function. Collectively, these experiments identified genomic instability in
pregnancy complications, the impact of defective DNA on trophoblast function, and a possible
RAGE-mediated mechanism during DNA-DSB repair.

Keywords: DSB, RAGE, placenta, ꝩ-H2AX, pATM, MRE11
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Introduction
The placenta is a critical organ during pregnancy, serving as the maternal-fetal interface.
Throughout pregnancy progression, fetus-derived trophoblasts play key roles in establishing and
maintaining placental function and growth (Knöfler et al., 2019). Early in pregnancy,
trophoblasts invade the uterine endometrium and myometrium, and convert resident spiral
arteries from high to low resistance vessels, in order to increase blood capacity (Knöfler et al.,
2019). Besides the importance of invasion, trophoblast cells are also specialized epithelial cells
that are responsible for facilitating appropriate exchange of nutrients, and wastes between
maternal and fetal compartments (Monson et al., 2017). These unique functions allow embryonic
settlement and meets the requirement of enhanced oxygen and nutrient exchange for proper fetal
development (Carter et al., 2015). Abnormal placentation is a feature of diverse pregnancy
complications including pre-term labor (PTL), intrauterine growth restriction (IUGR) and
preeclampsia (PE) (Knuth et al., 2015; Reuvekamp et al., 1999; Zhou et al., 1997). Failures in
placental formation result from inappropriate adaptation, shallow trophoblastic invasion,
increased trophoblast apoptosis, and insufficient spiral artery modification compromise placental
and embryonic growth, and development (Arshad et al., 2014; Bahr et al., 2014). Therefore,
trophoblast survival and invasion are essential for successful pregnancies, whereas trophoblast
apoptosis and dysfunction correlate with pregnancy complications, and such outcomes may be
underpinned with placental genomic instability (Mo et al., 2019).
DNA damage can be a part of the natural progression of the cell cycle and a means of
disposing aberrant cells (Ciccia & Elledge, 2010; Jackson & Bartek, 2009). However, exposure
to cytotoxic agents also results in defective DNA accumulation and negatively affects
physiological function. The most cytotoxic forms of DNA damage are DNA double-strand
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breaks (DNA-DSBs) where both strands of the helix are ruptured. If left unrepaired, these lesions
lead to disorders such as cancer, fibrosis, and neurodegeneration (Aparicio et al., 2014;
O’Driscoll, 2012). A functional repair system is fundamental in maintaining human health when
the harmful effects of DNA-DSBs are manifest. In response to DNA-DSBs, sequential events
involved in the DNA damage response (DDR) will detect, recruit various implicated molecules,
and repair DNA-DSBs via either the error-prone non-homologous end joining (NHEJ) pathway
or the error-free homologous recombination repair (HRR) (Aparicio et al., 2014; Ciccia &
Elledge, 2010; O’Driscoll, 2012). Specifically, during HRR, DSBs activate ataxia-telangiectasiamutated (ATM), which functions as the central controller of cellular responses to DNA damage
(Khanna et al., n.d.). ATM subsequently phosphorylates several downstream effectors, including
the activated histone variant ꝩ-H2AX, which marks the locations of DSBs, and the DNA damage
sensor MRE11-Rad50-Nbs1 (MRN) complex, which is essential at damaged DNA sites for end
processing (Smith et al., 2010).
The receptor of advanced glycation end products (RAGE) is a multi-ligand receptor
primarily expressed on cell membranes (Ramasamy et al., 2008). Common ligands for RAGE
include advanced glycation end-products (AGEs) and high mobility group box 1 (HMGB1). The
RAGE-ligand interaction is well-recognized for its modulation of chronic inflammatory diseases,
such as type 2 diabetes, varieties of neurodegeneration, and chronic obstructive pulmonary
disease (Kumar et al., 2017; Lewis, Hirschi, et al., 2017). More recently, our laboratory showed
that increased placental expression of membrane bound RAGE contributes to low trophoblastic
survival and insufficient invasion in a model of IUGR, suggesting a role of RAGE during
placental disease (Lewis, Mejia, et al., 2017). Although membrane bound RAGE is
predominately known for its function in inflammatory signaling, the nuclear isoform of RAGE
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(~64 kDa) was recently identified and demonstrated to be a positive regulator during DNA-DSB
repair in the lungs via HRR. During HRR events, RAGE is activated by DSB-induced ATM
kinase and function with MRN complexes in facilitating end-resectioning at the broken sites of
DNA (Kumar et al., 2017).
Although the accumulation of DNA damage has been observed in pathological placentas,
knowledge regarding the impact of genomic instability on pregnancy complications is still
limited (Furness et al., 2011). The current research sought to, (1) identify pregnancy
complications that are associated with genomic instability, (2) understand the effects of DNA
damage and its impact on trophoblast invasion, and (3) investigate the functional requirements of
RAGE during placental DNA-DSB sensing. Collectively, our study provides novel insights into
DNA damage-associated pregnancy complications and identifies the physiological relevance of
molecules in the repair process that may foreshadow the development of pregnancy complication
treatments.
Materials and Methods
Human Placental Tissues
All placental biopsies and slides from paraffin embedded placental tissues (gestational
diabetes (GDM), preterm labor (PTL), preeclampsia (PE) and term control (Cntl) were purchased
from the Research Center for Women’s and Infant’s Health BioBank, Ontario, Canada. In total,
there were 6 samples analyzed for each control and disease group. Samples were collected from
placentas, delivered in conjunction with delivery of the fetus, either vaginally or by C-section.
Sample demographics are shown in Table 2.1.
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Cell Culture and Treatments
The first trimester trophoblast cell line, Sw.71, and the choriocarcinoma cell line, Bewo,
were used for these studies (n = 10; n = number of experiments performed in triplicate). Both
lines were cultured in appropriate cell culture medium (Sw.71, RPMI; Bewo DMEM/F-12)
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin and streptomycin. DNADSBs were induced by treating cells with 1% cigarette smoke extract (CSE) for 24 h., or 30
μg/mL of Bleomycin (BLM; a commonly used chemotherapy drug for cancer treatment known
to induce DSBs.) for 1 h (Robles & Adami, 1998; Tomilin et al., 2011). A neutralizing RAGE
antibody (nAb; 2.4 μ/mL), was used in RAGE targeting studies, which blocks functional RAGE
via recognition of a 300-residue sequence of the receptor’s extracellular domain.
Cigarette Smoke Extract (CSE)
Nicotine is a key component in cigarette smoke that is associated with the development
of DBS (Argentin & Cicchetti, 2004). Preliminary studies in our laboratory (data not shown)
showed nicotine to be the main component of CSE. CSE was generated, as previously described
by Lewis et al. (2017) (Lewis, Mejia, et al., 2017). Briefly, one 2RF4 research cigarette
(University of Kentucky, Lexington, KY, USA) was continuously smoked with a vacuum pump
into 5 mL of RPMI or DMEM/F-12 medium (Mediatech, Manassas, VA, USA). The smokebubbled medium was filtered through a 0.22-μm filter to remove large particles. The resulting
medium was defined as 100% CSE and dilutions were made using RPMI or DMEM/F12
medium to a starting stock concentration of 20% CSE. CSE was made fresh for every treatment.

17

Immunofluorescence (IF)
Table 2.2 lists the antibodies used in these experiments. IF was performed on paraffin
embedded placental sections (n = 6; n = number of placental sections per condition) or
trophoblast cells (n = 6; n = number of experiments conducted in triplicate) as previously
performed in our laboratory (Arroyo et al., 2012). Briefly, serial sections were incubated
overnight with rabbit or mouse polyclonal antibodies against phospho-ꝩ-H2AX (Cell Signaling,
Danvers, MA, USA) or RAGE (R&D Technologies, Minneapolis, MN, USA). Anti-mouse
fluorescein or Texas red-conjugated secondary antibodies were incubated for 1 h; 40,6diamidino-2-phenylindole dihydrochloride (DAPI) was used for nuclear counterstaining. Slides
were viewed on a BX61fluoresce microscope using the appropriate excitation and emission filter
(fluorescein or rhodamine filters).
DNA Degradation
Genomic DNA samples were isolated using the genomic DNA mini kit (Thermo
Scientific, Rockford, IL, USA, #K182002). Briefly, placental and cell samples (n = 6) were
mixed with PBS, proteinase K, RNase A, and genomic lysis/binding buffer and incubated at
55 ⁰C for 10 min for protein digestion. 96–100% ethanol was added to the mixture and the
lysates were transferred to a spin column and spun down at 1000xg for 1 min. Spin columns
were washed twice with washing buffer and the DNA were eluted by the elution buffer. Sample
concentrations were tested using nanodrop and stored at -20 ⁰C prior to applications. Following
these steps, samples were electrophoresed on a 70% gel followed by a 1-h EtBr staining. The
extent of DNA degradation was quantified using the Image Studio software (LI-COR
Biosciences V5.2.5. Lincoln, NE, USA).
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Cytoplasmic and Nuclear Extraction
Subcellular protein extractions (n = 10; n = number of extractions performed) were done
by following the protocol included with the NE-PER Nuclear and Cytoplasmic Extraction
Reagents kit (Thermo Scientific, Rockford, IL, USA #78835). Essentially, placental tissues or
collected trophoblast cells were combined with CER I in microcentrifuge tubes and incubated on
ice for 10 min. CER II was then added to the tubes and vortexed for 5 s, incubated on ice for 1
min, then vortexed again for 5 s. The tubes were then centrifuged at 16,000x g and at 4 ⁰C for 5
min. Supernatants (cytoplasmic fraction) were collected into clean, pre-chilled, pre-labeled
microcentrifuge tubes and stored in a -80 ⁰C freezer before applications. The remaining pellets
were re-suspended with ice-cold NER supplemented with 50 U/mL of Benzonase and sonicated
for 5 times, 5 s each. Microcentrifuge tubes were again centrifuged at 16,000x g and at 4 ⁰C for
10 min. Supernatants (nuclear fraction) were collected into clean, pre-chilled, pre-labeled
microcentrifuge tubes and stored in a -80 ⁰C freezer before applications.
Immunoprecipitation
CSE or BLM treated cells were lysed in RIPA buffer, supplemented with 50 U/mL
Benzonase, and a cocktail of protease/phosphatase inhibitors. Lysates of 300 μg (n = 10; number
of experiments performed) were pre-cleared with A/G- agarose beads and incubated with
primary antibodies (phospho-(p)ATM-Cell Signaling Technology, Danvers, MA, USA,
mouse#4526 or MRE11-Cell Signaling Technology, Danvers, MA, USA, rabbit#4895) overnight
on a shaker at 4 ⁰C. On the following day, 20 μg of A/G-agarose beads (Santa Cruz, CA, USA)
were added to the mixture and incubated for 30 min at 4 ⁰C on a shaker. The bead-protein
complexes were collected by centrifugation and washed three times using RIPA buffer. 2x
Laemmle buffer supplemented with DTT (total volume of 20 μg) were added to the collected
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pellets and incubated at 100 ⁰C for 10 min to disassociate the beads and the attached proteins.
The supernatant contents were then analyzed using western blotting.
Western Blotting
Placental tissues (n = 6; n = number of placental samples per condition) and cell lysates
(n = 10; n = number of experiments performed; 10–20 μg) were separated on a 4–12% Bis-Tris
gel and transferred to a nitrocellulose membrane. Membranes were incubated overnight with
primary antibodies (phospho-ꝩ-H2AX-Cell Signaling Technology, Danvers, MA, USA, rabbit
#9718, RAGE-R&D, Minneapolis, MN, USA, goat #AF1145, p-ATM-Cell Signaling
Technology, Danvers, MA, USA, mouse #4526, MRE11-Cell Signaling Technology, Danvers,
MA, USA, rabbit #4895, β-Actin-Cell Signaling Technology, Danvers, MA, USA, rabbit #4967
or mouse #3700 and Lamin B1-Cell Signaling Technology, Danvers, MA, USA, rabbit#15068).
The membranes were then incubated with fluorescent secondary antibodies for an hour and
washed x3 with TBST the next day prior to imaging. Membranes were developed on a Li-COR
Odyssey CLx. Fluorescence densities were determined, and comparisons were made between
treated and control groups.
Real Time Cell Invasion
Real-time invasion of trophoblast cells (n = 10; n = number of experiments performed)
was measured using xCELLigence RTCA DP (Real Time Cell Analysis Dual Plate) instrument
from ACEA Biosciences Inc., San Diego, CA, USA on a 16 well CIM-Plate. These plates are
composed of an upper and lower chamber, each containing 16 wells. The top wells were coated
with Matrigel collagen and incubated for 4 h. Treated trophoblast cells (CSE or BLM) were
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plated in the top chamber at a concentration of 20,000 cells/well. The bottom chamber wells
were filled with 10% FBS RPMI. The plates were then place in the RTCA DP instrument and
invasion readings were taken every 15 min for 24 h.
Statistical Analysis
Endpoints obtained from DNA degradation studies and protein levels of (ꝩ-H2AX,
pATM, RAGE and MRN) were statistically compared. Differences in means ± SE were
specifically assessed using the Mann-Whitney U-test. Significant differences between the groups
were noted at p < 0.05.
Results
RAGE and Placental DNA-DSBs
When DNA-DSBs occur, such events are immediately followed by the phosphorylation
of the histone octamer H2AX. This newly phosphorylated protein is the first step in the
sequential process that leads to the identification of DSBs and activation of DDR, hence, ꝩH2AX is a reliable marker for DNA-DSBs (Kuo & Yang, 2008). To determine the expression
pattern of ꝩ-H2AX and the functional relevance of RAGE, human placental samples were
subjected to immuno-detection of ꝩ-H2AX and RAGE. Qualitative immunofluorescence staining
showed increased expression and colocalization of ꝩ-H2AX and RAGE in the PTL and PE
placentas when compared to Cntl (Figure 2.1A).
Genomic Instability in Pregnancy Complications
Timely repair of damaged DNA is essential in maintaining a healthy pregnancy, whereas
defective DNA accumulation has been observed in pathological placentas (Tadesse et al., 2014).
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To confirm the association of DNA damage in pregnancy complications, genomic DNA samples
extracted from human placentas complicated by pre-term labor (PTL), preeclampsia (PE) and of
normal gestation control (Cntl) were subjected to DNA degradation analysis via gel
electrophoresis. Figure 1B depicts characteristic DNA degradation. Quantification of the
resulting DNA degradation gel electrophoresis revealed elevated DNA fragmentation in the PE
(3.8-fold; p < 0.01) and PTL (3.2-fold; p < 0.01) samples when compared to controls (Figure
2.1C). These data suggest the presence of DNA damage in pathological PE and PTL placentas.
RAGE and Placental g-H2AX Nuclear Expression
After observing enhanced staining of RAGE and -H2AX in the PE and PTL placental
tissues, we next investigated nuclear expression of these proteins in these diseased placentas and
controls. A characteristic western blot for placental RAGE and ꝩ-H2AX is shown in Figure 2.2.
Immunoblotting of nuclear protein extractions from PE and PTL placental samples revealed
increased nuclear RAGE (4.4-fold; p < 0.0007 and 1.9-fold; p < 0.02) and ꝩ-H2AX (3.7-fold; p <
0.02 and 3.9-fold; p < 0.02) relative to normal gestation controls (Figure 2.2A,B).
RAGE Interacts with ATM and MRE11 During Placental DNA-DSBs
Previous work showed the recruitment of activated RAGE by p-ATM to the site of DNA
damage and RAGE modulation of MRE11 during DNA repair (Kumar et al., 2017). To implicate
a similar role for RAGE during placental DNA-DSBs, ATM- or MRE11-RAGE interactions
were verified by co-immunoprecipitation. In human placenta samples, immunoprecipitation of
pATM showed expression of RAGE in the PE and PTL placentas (1.7-fold; p < 0.008 and 1.5fold; p < 0.008; Figure 2.3A). Similarly, MRE11 complexed with RAGE was observed in PTL
and PE (2.2-fold; p < 0.03 and 3.5-fold; p < 0.03; Figure 2.3B).
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Role of RAGE in Trophoblast DNA Damage
To better understand RAGE function during DNA-DSBs, in vitro studies were performed
with two placental trophoblast cell lines: Sw.71 (cytotrophoblast) and Bewo cells
(syncytiotrophoblast). Exposure to tobacco smoke during gestation elicits numerous deleterious
outcomes, and in particular, exposure has been linked to trophoblastic apoptosis, DNA damage
and increased reactive oxygen species (Slatter et al., 2014). To understand the impact of cigarette
smoke on DNA integrity of placental cell types, Sw.71 and Bewo were treated with cigarette
smoke extract (CSE) or bleomycin (BLM; a known inducer of DSB) prior to assessing DNA
damage. CSE and BLM treatment increased DNA degradation in both Sw.71 (2.0-fold; p < 0.05
and 3.6-fold; p < 0.05) and Bewo (1.6-fold; p < 0.003 and 5.0-fold; p < 0.05) cells when
compared to the no treatment control cells (Figure 2.4A–D). To further elucidate the relevance of
RAGE during DNA damage, a neutralizing RAGE antibody (nAb), which blocks functional
RAGE, was used to treat cells in combination with CSE or BLM. When neutralizing RAGE was
used in tandem with CSE or BLM, DNA degradation was further increased in Sw.71 (55%; p <
0.02 and 50%; p < 0.03) and Bewo (49%; p < 0.0004 and 44%; p < 0.006) cells as compared to
cells treated with CSE or BLM alone (Figure 2.4A–D). In agreement with this DNA-DSB
scenario, in vitro induction of DSBs using CSE or BLM in trophoblast cells led to increased coexpression of ꝩ-H2AX and RAGE for both Sw.71 and Bewo cells as demonstrated by IF staining
(Figure 2.5).
Trophoblast RAGE and ꝩ-H2AX Nuclear Expression
To confirm RAGE and ꝩ-H2AX nuclear expression, western blot was performed on
nuclear fractions from trophoblast cells. CSE and BLM treatment of Sw.71 cells increased
nuclear expression of RAGE (1.4-fold; p < 0.02 and 13.8-fold; p < 0.02; Figure 2.6A,C,
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respectively) and ꝩ-H2AX (1.8-fold; p < 0.02 and 22.0-fold; p < 0.02; Figure 2.6B,D,
respectively). Similarly, CSE and BLM treatment of Bewo cells increased both RAGE (2.6-fold;
p < 0.02 and 3.6-fold; p < 0.02; Figure 2.7A,C, respectively) and ꝩ-H2AX (4.7-fold; p < 0.03 and
54.8; p < 0.02; Figure 2.7B,D, respectively).
RAGE Interacts with ATM and MRE11 During CSE and BLM Induced DNA-DSBs
DNA-DSBs induced in Sw.71 cells by CSE orchestrated the recruitment of RAGE by
pATM (2.8-fold; p < 0.03; Figure 2.8A) and MRE11 (2.8-fold; p < 0.03; Figure 2.8B) to the site
of DNA damage. CSE exposure also led to the recruitment of RAGE in Bewo cells by pATM
(27.8-fold; p < 0.04; Figure 2.8C) and MRE11 (3.0-fold; p < 0.03; Figure 2.8D). These data
identified RAGE as a probable substrate during the activation of placental DNA-DSBs repair
programs.
Trophoblast Dysfunction as a Consequence of Genomic Instability
The crucial invading function of trophoblasts is essential for successful placental
development. To determine the effects of DNA damage on trophoblast invasion, cell invasion
assays were performed using the Sw.71 cell line treated with CSE or BLM and invasion was
compared with the no treatment controls. Trophoblast invasiveness was decreased with CSE or
BLM treatment (Figure 2.9A,B: 2.4-fold; p < 0.0007 and 2.9-fold; p < 0.006). Tellingly, RAGE
nAbs administered with CSE or BLM further decreased invasiveness (Figure 2.9A,B: 4.9-fold; p
< 0.0004 and 3.7-fold; p < 0.006). These results suggest that DNA instability compromises
trophoblast invasion and contributes to anomalous pregnancy progression.
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Discussion
DNA double strand-breaks (DNA-DSBs) are known as one of the most damaging forms
of DNA complications as they can significantly compromise DNA integrity. Recently, a new
role for RAGE was established during DNA-DSB recognition, as well as repair programs
(Kumar et al., 2017). Previous reports showed increased DSBs in the PE placenta, but only scant
reporting on such DNA defects exist for pregnancies complicated with PTL or GDM (Arroyo et
al., 2012). In the current research, we assessed the qualitative expression of ꝩ-H2AX as a key
marker of DNA-DSBs (Smith et al., 2010). Detectable staining for ꝩ-H2AX was observed in the
PE and PTL placentas. This staining pattern correlated with RAGE localization in these
pathological placentas as well. To our knowledge, this is the first report demonstrating DNADSBs in the PTL placenta, and the finding of a correlation of ꝩ-H2AX and RAGE during PE and
PTL obstetric complications. We further confirmed that both proteins were increased in the
nucleus of trophoblast cells in both PE and PTL placentas. This is of interest as RAGE has
classically been thought to be a membrane receptor and in our experiments, we observed
potential tangential effects of RAGE in the nucleus and co-association with elevated nuclear
expression of the DNA-DSB marker ꝩ-H2AX (Mah et al., 2010; Sharma et al., 2012; Siddiqui et
al., 2015). To further confirm specific interactions of RAGE with DSB-associated complexes,
immunoprecipitation was performed for pATM or MRE11, followed by RAGE protein
detection. MRE11 and ATM are integral components of complexes that function in both the
recognition of DNA DSBs and repair programs, such as the preferred pathway involving
homologous end joining. MRE11 assembles into the MRN complex by binding with RAD50 and
NBS1 proteins. MRN complexes rapidly recognize and localize to DNA-DSB foci where it then
recruits and assists in ATM phosphorylation and similarly activated downstream DNA damage-
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induced proteins (Lamarche et al., 2010; Lavin et al., 2015; Uziel et al., 2003). Our results
demonstrate RAGE as a member of these complexes, suggesting the recruitment of RAGE to the
DNA-DSBs in the PE and PTL placentas and a novel role for RAGE in maintaining DNA
integrity. To further identify potential molecular interplay between RAGE and DNA-DSB
related proteins, DNA-DSBs were induced by CSE or BLM treatment of trophoblast cell lines
representing the syncytiotrophoblast (Bewo) and the invasive cytotrophoblast (Sw.71). The
induction of DNA-DSBs was confirmed by increased nuclear ꝩ-H2AX in the treated cell lines.
More interestingly, DNA damage was further augmented when RAGE neutralizing antibody was
added in conjunction with the DNA-DSB inducing treatments. Although the exact mechanisms
that control nuclear RAGE expression and its nuclear functions are not known, the RAGE
neutralizing antibody studies suggests that perhaps membrane bound activation of RAGE is
necessary for subsequent nuclear RAGE-mediated protection from DNA-DSBs. These results
portend a possible role for RAGE in genomic protection when DNA damaging stimuli encounter
trophoblast cells. Concomitantly, nuclear RAGE protein was also increased in the treated cells as
compared to controls. This suggests a possible role for this receptor in maintaining genomic
integrity in cell lines in a fashion similar to what was observed in the diseased placentas. Support
for a possible role of RAGE in pathways downstream of damage recognition, and at stages when
repair is initiated, was further verified in trophoblast cells where RAGE-associated with pATM
and MRE11 during CSE or BLM, induced DNA-DSBs.
Collectively, our results demonstrated the importance of DNA stability in the regulation
of placental/trophoblast behavior and invasion. More importantly, we have initiated a line of
research that expands the scope of RAGE biology to include nuclear effects that are necessary
for identifying DNA-DSBs and preventing notable loss of DNA integrity in the placenta. Further
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studies are needed to demonstrate specific roles for RAGE when placental cells experience
DNA-DSBs. For instance, a natural extension of the current work is to perform a series of
analyses that aim to characterize DNA-DSB incidence, recognition, and repair when RAGE
expression is targeted. Such in vitro and in vivo research should include the knocking out of the
RAGE gene in order to confirm a potential vital role in protecting genomic integrity in the event
damaging agents are encountered. This critical research would also confirm to what extent
RAGE utilization enhances DNA-DSB repair, in order to slow disease progression.
Conclusions
The results summarized in the present investigation provide an important initial step in
understanding DNA-DSBs and roles for RAGE that could foreshadow new avenues of study
with possible therapeutic utility.
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Figure 2.1: Genomic Instability in Pregnancy Complications.
(A) Increased staining and co-localization of DNA-DSBs (Green, ꝩ-H2AX), and RAGE (Red) was
observed during PE and PTL conditions. DAPI (Blue) was used for nuclear staining. (B) Gel
electrophoresis tail length revealed the degree of DNA damage. From left to right: Cntl, PE, and PTL).
(C) Quantifications of the fragmented DNA tail length from DNA electrophoresis (n = 6). Images (20x
magnification) are representative of experiments involving at least 6 placental sections from each group.
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Figure 2.2: RAGE and Placental ꝩ-H2AX Nuclear Expression.
(A) Characteristic western blot for these experiments. (B,C) Elevated -H2AX and RAGE protein
expression through western blot on PE and PTL samples when compared to controls.
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Figure 2.3: RAGE Interacts with ATM and MRE11 During Placental DNA-DSBs.
(A) Increased pATM-RAGE complex in PE and PTL samples when compared to controls. (B) Increased
MRE11-RAGE complex in PE and PTL samples when compared to controls.
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Figure 2.4: Role of RAGE in Trophoblast DNA Damage.
(A) Increased DNA degradation in CSE treated Sw.71 cells. (B) Increased DNA degradation in BLM
treated Sw.71 cells. (C) Increased DNA degradation in CSE treated Bewo cells. (B) Increased DNA
degradation in BLM treated Bewo cells. (A–D), worsened DNA damage was present with the addition of
neutralizing RAGE antibody in both cell types.
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Figure 2.5: Trophoblastic DNA-DSBs and RAGE (IF).
(A,B) Increased staining and co-localization of DNA-DSBs (green, ꝩ-H2AX), and RAGE (Red) was
observed from CSE or BLM treated Sw.71 (A) and Bewo (B). Images (40_ magnification) are
representative of experiments involving at least 6 different trophoblast experiments from each group.
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Figure 2.6: Trophoblast Cell, Sw.71, DNA-DSBs and RAGE (WB).
(A) Characteristic western blot for -H2AX and RAGE in CSE treated Sw.71 cells. (B,C) Elevated ꝩH2AX and RAGE protein expression in CSE treated cell samples when compared to controls. (D)
Characteristic western blot for ꝩ-H2AX and RAGE proteins in BLM treated Sw.71 cells. (E,F), Elevated
ꝩ-H2AX and RAGE protein expression in BLM treated cell samples when compared to controls.
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Figure 2.7: Trophoblast Cell, Bewo, DNA-DSBs and RAGE (WB).
(A) Characteristic western blot for -H2AX and RAGE in CSE treated Bewo cells. (B,C) Elevated ꝩH2AX and RAGE protein expression in CSE treated cell samples when compared to controls. (D)
Characteristic western blot for -H2AX and RAGE proteins in BLM treated Bewo cells. (E,F) Elevated ꝩH2AX and RAGE protein expression in BLM treated cell samples when compared to controls.
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Figure 2.8: RAGE Interacts with ATM and MRE11 During CSE and BLM Induced DNA-DSBs.
Increased pATM-RAGE (A) or MRE11-RAGE (B) complexes in CSE treated Sw.71 when compared to
controls. Increased pATM-RAGE (C) or MRE11-RAGE (D) complexes in CSE treated Bewo cells when
compared to controls.
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Figure 2.9: Trophoblastic Dysfunction as a Consequence of Genomic Instability.
(A) Decreased invasion in CSE treated Sw.71 cells and further hindrance in invasion when nAb was cotreated with CSE. (B) Decreased invasion in BLM treated Sw.71 cells, the invasion further diminished
when nAb was co-treated with BLM.
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Table 2.1: Demographical Data from Collected Placental Samples.
Parameters between control and disease placental groups (n = 6) were analyzed for statistical significance
(p<0.05) using the Kruskal-Wallis test.

Table 2.2: List of Antibodies used per Application.
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Abstract
The mechanistic target of rapamycin (mTOR) pathway is involved in the function and
growth of the placenta during pregnancy. The mTOR pathway responds to nutrient availability
and growth factors that regulate protein expression and cell growth. Disrupted mTOR signaling
is associated with the development of several obstetric complications. The purpose of this study
was to identify the differential placental expression of various mTOR-associated proteins in the
placenta during normal gestation (Control), gestational diabetes mellitus (GDM), intrauterine
growth restriction (IUGR) and preeclampsia (PE). Immunohistochemistry localized activated
proteins (phospho; p) mTOR, pp70, p4EBP1, pAKT and pERK. Real-time PCR array was
performed to show differing placental expression of additional mTOR- associated genes.
Western blot was performed for pAMPK protein. We observed: 1) increased pmTOR during
GDM and decreased pmTOR during IUGR and PE, 2) increased pp70 during IUGR and
decreased pp70 during GDM and PE, 3) increased p4EBP1 during GDM, IUGR, and PE, 4)
increased pAKT during GDM, 5) increased pERK during IUGR, 6) differential placental
expression of mTOR pathway associated genes and increased pAMPK during GDM and PE. We
conclude that regulation of the mTOR pathway is uniquely involved in the development of these
obstetric complications. Insights into this pathway may provide avenues that if modify may help
alleviate these diseases.

Keywords: mTOR, placenta, PE, IUGR, GDM
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Introduction
During gestation, the placenta is responsible for mediating the interface between mother and
fetus and notable functions include the regulation of gas exchange, nutrition availability, and
waste removal (Aires, 2015). Trophoblasts are an essential cell population in the placenta that
confers beneﬁts during the development of the fetus as normal trophoblast function is
necessary in the formation of a functioning placenta. Another pertinent feature of the
trophoblast biology is their involvement in nutrient transport, an important step for proper
fetal development (Lager & Powell, 2012). Aberrant trophoblast function has been implicated in
several pregnancy complications, including preterm delivery (PTL) intrauterine growth
restriction (IUGR), preeclampsia (PE) and gestational diabetes mellitus (GDM). PTL is associated
with up to 70 % of neonatal death, increased incidence of cerebral palsy, neurological defects
and pulmonary disorders in the neonate (Challis et al., n.d.). IUGR is an obstetric complication
that affects up to 10 % of all pregnancies and is linked to an increased risk of morbidity and
mortality for the fetus, characterized by low birth weight (below the 10th percentile) (B. L. Bahr
et al., 2014; Mejia et al., 2017). Other IUGR complications include perinatal hypoxia and
asphyxia, cerebral palsy, and persistent pulmonary hypertension of the newborn (Arroyo &
Winn, 2008; B. Bahr et al., 2014; Mejia et al., 2017).In addition, several studies reported a longterm sequelae of IUGR complications including adult hypertension, heart disease, stroke, and
diabetes (Arroyo et al., 2008). There is a risk of up to 44 % of PTL associated with IUGR
complications (Delpisheh et al., 2008). PE pregnancies are characterized by high blood pressure
after the 20th week of pregnancy; 140 mm Hg (systolic) or 90 mm Hg (diastolic), production of
protein in the urine (300 mg in 24 h) and hypoxic placental tissue (Chaudhari et al., 2003;
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Emsley et al., 1998; Nelson & Grether, 1999). In extreme forms, PE is also characterized by
cerebral and visual disturbances, pulmonary edema, hemolysis, elevated liver enzymes and
even seizures. Interestingly PE accounts for around twenty percent of induced PTL (Chaudhari
et al., 2003; Obert et al., 1998). PTL observed during PE is due to the necessity of early delivery
of the placenta, and in term the fetus, to alleviate the symptoms associated with this disease
(Obert et al., 1998). GDM is a state where the pregnant body has become sufﬁciently resistant to
the glucose lowering effects of insulin that hyperglycemia develops (Magee et al., 2014). This
pathology affects up to 12 % of all pregnancies and can lead to higher risk of short- and longterm maternal and fetal complications. The list of maternal and fetal complications associated
with GDM is lengthy, including maternal gestational hypertension and PE, shoulder dystocia,
caesarian delivery, hyperglycemia in the infant, and the development of type 2 diabetes for both
mother and child (Jarmuzek et al., 2015).
The mammalian target of rapamycin (mTOR) protein is a phosphatidylinositol kinaseregulated protein kinase, which functions in the regulation of cell growth and protein
transcription in response to nutrient availability (Jansson et al., 2006; Wullschleger et al., 2006).
This protein has been localized to syncytiotrophoblast cells (Knuth et al., 2015). This expression
proﬁle suggests its role in regulating trophoblast proliferation and invasion by serving as a
nutrient sensor during pregnancy. In the scheme of its pathway, mTOR is activated by
phosphorylation via the phospha-tidylinositol-3 kinase (Pl3K)/AKT signaling axis (Arroyo et al.,
2009; Knuth et al., 2015). Downstream effectors, including the 70-kDa ribosomal protein S6
kinase 1 (p70S6K) and the eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1),
are known to regulate translation initiation and protein synthesis (Arroyo et al., 2009; Knuth et
al., 2015; Mejia et al., 2017). Under physiologic conditions, p70S6K is also mediated through the
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extracellular regulated kinase (ERK) pathway (Bigham et al., 2014; Chaudhari et al., 2003;
Zhifang et al., 2005). In concordance with the suggested role of mTOR during pregnancy, studies
have shown that the inhibition of mTOR activation results in decreased trophoblast invasion in
an in vitro model, and elevated expression of mTOR as compensation of IUGR in ovine near
term (Arroyo et al., 2009).
Despite extensive research, relationships between pathological conditions during pregnancy
and placental mTOR signaling in the aspect of human gestation remains largely unexplored due
to ethical issues. In the current study, an initial critical step is taken to establish the fundamental
knowledge on this matter by examining differential expression of mTOR and associated
molecules and accessing additional mTOR related genes in patients with IUGR, PE and GDM.

Materials and Methods
Human Placenta Samples
All frozen human term placental samples and slides (IUGR, PE, GDM, and control) were
purchased from the Research Center for Women's and Infant's Health BioBank, Ontario, Canada.
IUGR diagnosis was conﬁrmed by ultrasound showing placental insufﬁciency with uterine
Doppler and absent end diastolic ﬂow (AEDV) and an estimated fetal weight below the 10th
percentile. The diagnosis of gestational diabetes mellitus (GDM) was based on 75 g of oral
glucose tolerance test (OGTT). All patients diagnosed with GDM were on special diets to
regulate this condition. PE diagnosis was based on elevated blood pressure (systolic blood
pressure >160 mm Hg and/or a diastolic blood pressure >110 mm Hg) and proteinuria (≥5).
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There were 10 samples analyzed for each control or pathologic group. Samples were originally
collected from placentas delivered in conjunction with delivery of the fetus either vaginally or by
C-section. Placental samples demographics are shown in Table 3.1.
Immunoﬂuorescence (IF)
IF was performed on parafﬁn embedded placental sections as previously
performed in our laboratory [20]. Brieﬂy, serial sections were incubated overnight with
rabbit polyclonal antibodies against phospho (p) AKT, pERK, pmTOR, pp70, p4EBP1 (all
from cell Signaling, Danvers, MA) or cytokeratin 7 (for trophoblast localization; Dako,
Carpinteria, CA). Anti-mouse ﬂuorescein or Texas red-conjugated secondary antibody
was incubated for 1 h; 40,6-diamidino-2-phenylindole dihydrochloride (DAPI) was used
for nuclear counterstaining. Slides were viewed on an BX61 ﬂuoresce microscope using
the appropriate excitation and emission ﬁlter (ﬂuorescein or rhodamine ﬁlters) and scale
bars are set at 100 mm. Individual images (n = 5 for each sample) were analyzed using
ImageJ software evaluating red or green staining intensity.

mTOR PCR Array
Placental RNA was isolated using the Tri-reagent method (Sigma, Saint Louis,
MO) and in accordance with the instructions suggested by the manufacturer. RNA was
quantiﬁed using a Nanodrop and cDNA was produced through reverse transcription using
the RT2 First Strand Kit. A human mTOR signaling RT2 Proﬁler PCR 96-well array
(Quiagen, Germantown, MD) was used to determine expression of mTOR related genes.
Brieﬂy, samples containing RT2 SYBR green, cDNA and RNase water for a total
volume of 270 mL were prepared as suggested. 25 mL of PCR components was added
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to each Proﬁler plate well, sealed, centrifuge and Quantitative real time PCR was
completed. PCR array contains 5 housekeeping reference genes (Beta-actin, Beta-2microglobulin, GAPDH, Hypoxanthine phosphoribosyltransferase 1, and Ribosomal
protein, large, P0) and a panel of proprietary controls to monitor genomic DNA
contamination (GDC) as well as real-time PCR efﬁciency (PPC). Experiments were run in
triplicate and analyzed using software provided by Qiagen.
Cell Culture
We utilized an immortalized ﬁrst trimester trophoblast Swan71 cell line (SW71; a
generous gift from Dr. Gil Mor at Yale University) for these studies [21]. Cells were cultured in
RPMI medium (Mediatech, Manassas, VA) supplemented with 10 % fetal bovineserum (FBS)
and 1% penicillin and streptomycin. Cells were treated in 6 well plates and used for protein
analysis.
Cell Treatments
Control cells were incubated in media alone (n = 10); the ﬁrst group of
experimental cells were passaged 6 times in media supplemented with 16 mM glucose
prior to incubation, or in hypoxic conditions (2% O2; n = 10). Treatments were conducted
for 24 h. Cells were then detached using Trypsin EDTA (0.05 %; Thermo Fisher, Waltham,
Massachusetts) and lysed using RIPA buffer (Thermo Fisher, Waltham, Massachusetts)
for immunoblotting studies.
Immunoblotting
Western blot analysis was used to determine the expression level of pAMPK and
pmTOR in control, GDM, IUGR and PE placental samples or in lysates of control and
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treated cells as previously described (n = 10) (Arroyo et al., 2009). Cell lysates (50 mg)
were separated on a 10% SDS-Page gel and transferred onto nitrocellulose membranes. The
membrane was blocked and incubated with antibodies against pAMPK (Cell Signaling
Technology, Danvers, MA), pmTOR (Cell Signaling Technology, Danvers, MA) or β actin
(1:400; Santa Cruz Biotechnology, Dallas, Texas). Membranes were then incubated with
secondary IRDye antibodies (680RD donkey-anti goat and 680RD donkey-anti rabbit;
LICOR Lincoln, NE) at room temperature for an hour. Membranes were developed on a LiCOR Odyssey CLx. All results were normalized to β actin as our loading control.
Fluorescence densities comparisons were made between treated and control groups.

Statistical Analysis
Comparisons between mTOR gene array differences and pAMPK and pmTOR
protein levels were evaluated. Data were analyzed for normality and differences using
the Mann–Whitney test with P < 0.05 designating signiﬁcantly different values. Table 1
was analyzed by Kruskal–Wallis test for statistical signiﬁcance with P < 0.05 as statistically
signiﬁcant. All results represent the mean S.E.M.

Results
Placental Samples
Demographics of human placental sample donors were analyzed for significant
differences between control GDM, IUGR and PE patients. There were no significant differences
in maternal age while there were differences in gestational age and fetal weights from control
and disease pregnancies (Table 3.1).
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Placental p-mTOR, p-p70 and p-4EBP1
mTOR signaling proteins are expressed in the placenta and are known to be differentially
regulated during pregnancy complications (Arroyo et al., 2009). We first wanted to determine
expression and localization of mTOR and secondary molecules. We observed that
immunofluorescence of pmTOR was qualitatively increased in the GDM placentas compared to
controls (Figure 3.1A). In contrast, this protein was decreased in the PE placenta and reductions
in expression were much more pronounced in the IUGR placenta (Figure 3.1A). For
immunofluorescence protein quantifications, we measured fluorescent emission from 6 different
fields using ImageJ. This was repeated in 5 different pictures from each placental condition.
pmTOR immunofluorescence intensity quantification confirmed the previous stated results
(Figure 3.1B). In terms of localization, p-mTOR was observed in the syncytiotrophoblast layer
for all placentas studied, while it was observed in the cytotrophoblast layer predominantly in the
control and GDM placenta. Interestingly, p-p70 was increased and localized to both layers of
trophoblast cells in the IUGR placenta (Figure 3.2A). There was markedly less p-p70 observed in
the control, GDM and PE placentas as compares to IUGR patients. Quantification of pp70
immunoﬂuorescence intensity conﬁrmed these results (Figure 3.2B). p4EBP1
immunoﬂuorescence revealed elevated staining in all the disease placentas studied (GDM, IUGR
and PE) compared to controls (Figure 3.3). Quantiﬁcation of p4EBP1 immunoﬂuorescence
intensity conﬁrmed these results (Figure 3.3B)
Placental p-ERK and p-AKT
Regulation of mTOR and p70S6K activity is mediated by phosphatidylinositol-3
kinase/AKT signaling or by the activation of the extracellular regulated kinase (ERK) pathway.
Therefore, we next assessed the activation of these molecules in the various placentas. We
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observed that ERK protein was only increased in the IUGR placenta with no visible differences
in GDM and PE placenta compared to controls (Figure 3.4). Quantiﬁcation of pERK
immunoﬂuorescence intensity conﬁrmed these results (Figure 3.4B). Extremes in p-AKT
expression among the groups appeared in placentas from IUGR and PE where detectible
increases were apparent in the PE placenta and lessened expression in the IUGR placenta when
compared to controls (Figure 3.5). Quantiﬁcation of pAKT immunoﬂuorescence intensity
conﬁrmed these results (Figure 3.2B)

mTOR Associated Gene Activation
We examined gene activation of several mTOR associated molecules to further determine
the differences in mTOR signaling between control, GDM, IUGR and PE placentas. We ﬁrst
considered upstream regulators of mTOR signaling. AKT1S1 and AKT3 are known regulators of
mTOR activity (Zhifang et al., 2005). While AKT1S1 is negative regulator, AKT 3 positively
regulates activation of this molecule. We observed that AKT1S1(1.7-fold, p < 0.05) and AKT3
(2.4-fold, p < 0.05) were increased in the GDM placenta (Figure 3.6A). In contrast, AKS1S1 was
only decreased (1.4-fold, p < 0.05) in the IUGR placenta compared to controls (Figure 3.5A).
CAB39 and CAB39 L are negative upstream regulators of mTOR signaling. CAB39 was
increased in both GDM (1.7-fold, p < 0.05) and PE (1.7-fold, p < 0.05) placenta compared to
controls (Figure 3.6B). Increased CAB39 L gene activation (2.4-fold, p < 0.05) was only
observed in the GDM placenta (Figure 3.6B) (Bigham et al., 2014). We observed that both
PAKAA1 (8.6-fold, p< 0.02) and PRKAA2 (8.6-fold, p < 0.02), molecules know to (function),
were upregulated in the GDM placenta compared to controls (Figure 3.6C). PTEN is an mTOR
negative regulator involved in the control of cell growth and division (Milella et al., 2017). GDM
placenta was the only tissue that differentially regulated the gene (increase; 5.3- fold; p < 0.009)
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compared to controls (Figure 3.6D). DEPTOR inhibits kinase activity of mTOR signaling
(Mparmpakas et al., 2012). This gene was altered only in the GDM placenta as compared to
controls (increased; 2.3-fold; p < 0.004), Figure 3.6E). STK11 is a tumor suppressor that
regulates cell growth and behavior (Lai et al., 2013). STK11 was only affected in the GDM
patients (increased; 1.8-fold; p < 0.03) compared to controls (Figure 3.6F). Placental apoptosis
and metabolism are important for proper placental function and pregnancy success. The
STRADB gene is associated with the regulation of both apoptosis and metabolism (Mahoney et
al., 2009) and is known to be a negative regulator of mTOR. We observed decreased STRADB
(1.9-fold; p < 0.0008) in the GDM placenta while no changes were observed in the other
diseased tissues compared to controls (Figure 3.6G).
We next investigated some key genes that downregulate mTOR signaling. HIF1A
functions as a hypoxia responsive regulator that activates transcription of many genes involved
in energy metabolism, angiogenesis, and others (Harada et al., 2009). Interestingly, increased
expression of this gene was only observed in the GDM placenta (1.3-fold; p < 0.03) when
compared to controls (Figure 3.6H). ULK1 is a kinase involved in autophagy (Kim et al., 2011).
Similarly, this gene was signiﬁcantly increased (5.7-fold; p < 0.03) only in the GDM placenta
compared to controls (Figure 3.7A). The RPS6 gene encodes a cytoplasmic ribosomal protein
that is a component of the 40S ribosomal subunit involved in the regulation of cell growth and
proliferation (Magnuson et al., 2012). GDM and PE placenta had increased RSP6 gene activation
(each at 1.7-fold; p < 0.02) while it was decreased in the IUGR placenta (>25.0-fold; p < 0.02)
compared to controls (Figure 3.7B). The PPP2CA gene encodes a protein implicated in the
negative control of cell growth and division (Li et al., 2013). Interestingly, this gene was only
altered in the GDM placenta. When comparing to control, we observed a 2.8-fold (p < 0.003)

53

increase in the GDM placenta (Figure 3.7C). The EIF4E family of genes are involved in the
initiation of protein synthesis. The EIF4E gene was increased (3.1- fold; p < 0.003) in the
placenta from GDM patients compared to controls (Figure 3.7D). In contrast, placental
EIF4EBP1 gene expression was decreased (1.4-fold; p < 0.003) in the GDM patients compared
to controls (Figure 3.7D).
Lastly, we evaluated some mTOR signaling associated genes that are involved in diverse
processes of cell signaling and behavior. The PRKAA family of genes include the PRKAA1 and
PRKAA32 genes. These genes code for the catalytic subunit of the 5'-prime-AMP-activated
protein kinase (AMPK). AMK regulates metabolic enzymes that monitor cell energy status and it
is also associated with insulin sensitivity (Bigham et al., 2014). Both PRKAA1 (60-fold; p <
0.02) and PRKAA2 (10-fold; p < 0.02) were signiﬁcantly increased in the GDM patients
compared to controls (Figure 3.7E). The PIK3 family of proteins are involved in the regulation
of several cellular functions such as cell growth, proliferation and survival. The PIK3C3 gene
was upregulated in both GDM (4.0-fold; p < 0.05) and IUGR placentas (5.2-fold; p < 0.05) with
no differences observed in the PE tissues (Figure 3.7F). In contrast PIK3CA gene expression was
increased in the GDM (61-fold; p < 0.05), IUGR (39-fold; p < 0.05) and PE (47-fold; p < 0.05)
patients compared to controls (Figure 3.7F). Similarly, PIK3CB gene was increased in the GDM
(93.0-fold; p < 0.05), IUGR (4-fold; p < 0.05) an PE placenta (2-fold; p < 0.05) when compared
to controls (Figure 3.7F). Both PIK3CB (1.2-fold; p < 0.05) and PIK3CB (4.4-fold; p < 0.05)
were increased only in the GDM when compared to control tissues (Figure 3.7F). MAPK1
(ERK2) is involved in multiple biochemical signals, and in a wide variety of cellular processes.
In the pathological placentas, we observed a signiﬁcant decrease (1.2-fold; p < 0.05) of MAPK1
gene expression only in the GDM placenta when compared to controls (Figure 3.7G). CDC42
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gene encodes a small GTPase of the Rho-subfamily protein involve in of control diverse
cellular functions and cell cycle progression (Endo et al., 2009). We observed a decreased
(2.0-fold; p < 0.0009) in the activation of the CDC42 gene only in the GDM tissues
compared to controls (Figure 3.7H).
AMPK and mTOR
Together with mTOR, AMPK is one of the major nutrient dependent pathways
associated with the regulation of homeostasis (Inoki et al., 2012). We next investigated activated
(phospho) AMPK in control and pathological placental samples. We observed increased
pAMPK in the GDM, and PE samples (28-fold; 26-fold; p < 0.05) while there were no
differences in the IUGR placentas as compared to controls (Figure 3.8A-C). To further
characterized AMPK and mTOR correlation, trophoblast cells were treated with glucose (to
mimic GDM) or hypoxia (to mimic IUGR). We observed increased pAMPK and pmTOR (15fold and 3.5-fold; p < 005) when cells were treated with 16 mM glucose compared to control
(Figure 3.9A-B). In cells treated with hypoxia, we observed increased pAMPK (10-fold; p <
0.05) while mTOR was decreased (1.4-fold; p < 0.05) when compared to controls (Figure 3.9CD).
Discussion
Proper placental function is essential for fetal health and development. For a successful
pregnancy, the placenta must efﬁciently deliver nutrients and oxygen to the fetus to meet growth
demands (Kimball et al., 2015). This process becomes compromised during complicated
pregnancies such as preeclampsia and intrauterine growth restriction and each such impairment
likely affects fetal development. Interestingly, insights into the mechanistic pathways that
contribute to these pathologies are incomplete. Studies examining the processes and mediators
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that inﬂuence trophoblast invasiveness may be instrumental in providing novel targets for future
therapies that combat these obstetric complications. In the present study we assessed the
mammalian target of Rapamycin (mTOR) and related signaling molecules in the placenta of
mothers affected by GDM, IUGR or PE. mTOR is a kinase that regulates cellular growth when
activated by phosphorylation in response to growth factors and nutrients (Knuth et al., 2015).
This protein is expressed in the trophoblast of the human placenta and it has been shown to have
an important role during placental development (Arroyo et al., 2009). Placental staining
conﬁrmed the presence of mTOR and related proteins (p70 and 4EBP1) in the trophoblast villi
of the human placenta. When comparing the activated mTOR related proteins between control
and the diseases pregnancies, we observed that active mTOR protein was increased during
GDM, while decreased in the IUGR and PE placentas. These results are expected as activity of
mTOR is considered nutrient dependent and has been shown to be increased during GDM while
decreased nutrient availability and diminished expression of mTOR family members are
observed during the development of IUGR and PE (Jansson et al., 2006; Mejia et al., 2017; Roos
et al., 2007). In terms of pp70 we observed decreased in the GDM placenta and increased during
IUGR when compared to controls. In contrast with our results, Sati et al. observed increased
pp70 in the GDM placenta as compared to controls (Sati et al., 2016). Perhaps this discordance
could be explained by the fact that the placental samples in our studies were obtained from GDM
patients in which diabetes was control with dies while the GDM samples use by Sati et al.,
patients were treated with and on oral insulin-sensitizing antidiabetic medication. Active
4EBP-1was increased in diseased placentas compared to control. This observation suggests that
perhaps an alternative mechanism of regelation could be responsible
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for 4EBP-1activation in placentas affected by GDM, IUGR or PE (Arroyo et al., 2009; Dreyer et
al., 2008; Jansson et al., 2006)
AKT activation has been correlated with mTOR activation, so we also investigated active
placental AKT in complicated pregnancies and controls (Knuth et al., 2015). Interestingly we did
not observe appreciable differences in activated AKT between the placentas of pregnancies
complicated by GDM, IUGR, PE and control. This discordance between AKT activation and
mTOR has been previously observed in our lab suggesting that perhaps regulation of placental
mTOR activation may be regulated differently between GDM and IUGR or PE and that these
differences are independent of AKT (Knuth et al., 2015; Hirschi et al., 2020). Because reports
have shown a correlation between activation of p70 and ERK, we investigated ERK activation in
diseased placentas and controls. There were similar levels of ERK activation in GDM or PE
samples, while higher activation was observed during IUGR when compared to controls. These
ﬁndings suggest a direct correlation between placental ERK and p70 during IUGR that is not
present in the GDM and PE placentas. All these data suggest that regulation of the mTOR
pathway is uniquely involved in the development of obstetric complications.
To better understand mTOR function, we investigated mTOR related gene activation in diseased
and control placentas. Interestingly, the majority of genes were only affected in the GDM
placental samples when compared to controls. The genes differentially impacted in GDM
conditions (AKT1S1, AKT3, PRKAA1, PRKAA2, PTEN, DEPTOR, STRADB, PPP2CA,
HIF1A, PPP2CA, MAPK1 and CDC42) were mostly associated with negative regulation of
mTOR activity. This thematic outcome suggests a possible mechanistic attempt by the placenta
to maintain homeostasis in the presence of high glucose levels in maternal circulation. The
PI3KC genes are mTOR positive regulators that had increased expression in the GDM placentas
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(PIK3C3, PIK3CA, PIK3CB, PIK3Cd and PIK3CG). These genes are responsible for making the
catalytic portion of PI3K. PI3K are enzymes involved in cellular functions and are positive
regulators of mTOR. Our results suggest that activation of this gene could be important in the
increased mTOR activity observed in the GDM placenta (Liu et al., 2009; Hirschi et al., 2019).
Interestingly, RPS6 (involved in the initiation of protein synthesis) gene expression
was upregulated in the GDM and PE placentas and decreased in the IUGR placenta when
compared to controls (K M Hirschi et al., 2019). In contrast, active p70 protein was decreased
during GDM and PE while increased during IUGR. This paradigm was unexpected as p70
protein is often correlated with the activation of RPS6, suggesting that perhaps a different
regulatory program manages RPS6 expression independent of p70 (Ruvinsky et al., 2005). A
similarly functioning regulator, EIF4E, also inﬂuences the initiation of protein synthesis and it is
known to be regulated by 4EBP-1 (Siddiqui & Sonenberg, 2015). We observed increased EIF4E
gene expression while EIF4EBP1 (4EBP-1) was decreased during GDM with no changes for
IUGR and PE when compared to controls. This combined observation was unexpected because
EIF4EBP1phosphorylation releases EIF4E and initiates protein synthesis (Truitt et al., 2015).
Furthermore, we observed increased active placental EIF4EBP1staining in all the disease
placentas when compared to controls. This suggests that post transcriptional regulation of these
proteins is possible in the diseased placentas when compared to controls.
AMPK is a regulator of cell homeostasis that regulates the mTOR pathway (Xu et al.,
2012). This AMPK pathway is known to block mTOR activation and is involved in trophoblast
differentiation (Drewlo et al., 2020). Interestingly, there were several genes associated with the
AMPK and mTOR pathways that were changed in the pathological placentas when compared to
controls. The PRKAA family (PRKAA1 and PRKAA32) of genes are genes associated with
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AMPK activation. We observed that two members of this family were both increased in the
GDM placentas with no differences detected in the IUGR and PE placentas. These two
molecules are negative regulators of mTOR, suggesting again that an alternative mechanism
elicits increased mTOR in response to high nutrient availability. At the same time, we detected
increased expression of the STK11 gene in the GDM placentas when compared to controls. This
STK11 activation supports increased PRKAA1 and PRKAA32 observed during this condition.
CAB39 and CAB39 L are genes associated with the activation of STK11 (Shackelford & Shaw,
2009). Concurrent with the increased expression of this gene, we observed increases of both
CAB39 and CAB39 L during GDM. Altogether, these results implicate a likely role for AMPK
in the development of placental pathologies. The role of activated AMPK was further conﬁrmed
by protein levels in the pathological placentas and control. As expected, AMPK protein
activation was increased in the GDM placenta. There were no differences in APMK activation
between the IUGR and control tissues. Surprisingly, we also observed activation of AMPK
protein in the PE placenta. Because of these AMPK results, we investigated the correlation
between glucose (mimics GDM environments) or hypoxia (mimics PE environment). We
detected signiﬁcantly increased protein activation of both mTOR and AMPK. These ﬁndings
suggest that glucose is a major factor in increasing these two proteins in GDM pregnancies.
AMPK was also increased during hypoxia. The correlation between aberrant oxygen tension and
AMPK has been previously established and suggest that hypoxia may be responsible for the
regulation of mTOR activity in the villi trophoblast during PE. Taken together, the current
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research opens the door to the possibility that these important signaling molecules could be
targeted as a means of effectively ameliorating obstetrics complications including GDM, PE and
IUGR.
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Abbreviations
GDM

Gestational Diabetes Mellitus (GDM)

IUGR

Intrauterine Growth Restriction (IUGR)

PE

Preeclampsia

PTL

Preterm delivery

mTOR

The mammalian target of rapamycin

p70S6K

Ribosomal protein S6 kinase beta 1

4EBP1

Eukaryotic translation initiation factor 4E-binding protein 1

AKT

Protein kinase B

ERK

Extracellular regulated kinase

AMPK

5' AMP-activated protein kinase

SW71

Swan 71 first trimester trophoblast cells

CAB39

Calcium-binding protein 39

PAKAA1

Protein Kinase AMP-Activated Catalytic Subunit Alpha 1

PRKAA2

Protein Kinase AMP-Activated Catalytic Subunit Alpha 2

PTEN

Phosphatase and tensin homolog

DEPTOR

DEP domain-containing mTOR-interacting protein

STK11

Serine/threonine kinase 11

STRADB

STE20 Related Adaptor Beta

HIF1A

Hypoxia Inducible Factor 1 Subunit Alpha

ULK1

Unc-51 Like Autophagy Activating Kinase 1
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RSP6

Ribosomal Protein S6

PPP2CA

Protein Phosphatase 2 Catalytic Subunit Alpha

EIF4E

Eukaryotic Translation Initiation Factor 4E

PRKAA

5'-AMP-activated protein kinase catalytic subunit alpha-2

PIK3

Phosphatidylino-sitol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha

MAPK1

Mitogen-activated protein kinase 1

CDC42

Cell division control protein 42.
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Figure 3.1: Placental phosphor (p) mTOR Staining.
Immunofluorescence (IF) staining showed increased pmTOR expression during GDM but decreased in
the IUGR and PE placentas. 60 x scale bars are 50mm (A). Quantification of mTOR staining is shown in
B.
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Figure 3.2: Placental phospho (p) p70.
Immunoﬂuorescence (IF) staining showed increased pp70 expression during IUGR but decreased in the
GDM and PE placentas. 60 x scale bars are 50 mm (A). Quantiﬁcation of pp70 staining is shown in B.
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Figure 3.3: Placental phospho (p) 4EBP1.
Immunoﬂuorescence (IF) staining showed increased p4EBP1 expression during in the GDM, IUGR and
PE placenta as compared to controls. 60 x scale bars are 50 mm (A). Quantiﬁcation of p4EBP1 staining is
shown in B.
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Figure 3.4: Placenta ERK Activation.
Immunoﬂuorescence (IF) staining showed increased pERK expression in the IUGR placenta. 60 x scale
bars are 50 mm (A). Quantiﬁcation of pERK staining is shown in B.
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Figure 3.5: Active AKT.
Immunoﬂuorescence (IF) staining showed that pAKT was increased in GDM but decreased in the IUGR
placenta. 60 x scale bars are 50 mm (A). Quantiﬁcation of pAKT staining is shown in B.
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Figure 3.6: AKT, EIF4E, PRKAA, PTEN, DEPTOR, STK11, STRADB and HIF1A Gene Activation.
A human mTOR signaling RT2 Proﬁler PCR 96-well array demonstrated a differential gene activation
between control, IUGR, PE and GDM placental tissues (n = 10). Representative data are shown with *P ≤
0.05 compared to controls.
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Figure 3.7: ULK1, RPS6, PP2CA, EIF4E, PRKAA, PIK3C, MAPK1, and CDC42 Gene Activation.
A human mTOR signaling RT2 Proﬁler PCR 96-well array demonstrated a Differential gene activation
between control, IUGR, PE and GDM placental tissues (n = 10). Representative data are shown with *P ≤
0.05 compared to controls.
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Figure 3.8: Activated Placental AMPK in IUGR, PE and GDM Patients.
Immunoblot was performed for p-AMPK protein determination. AKT was activated in the GDM and PE
placentas (n = 10). Representative data are shown with *P ≤ 0.05 when compared to controls.

Figure 3.9: Activated Trophoblast AMPK During Glucose and Hypoxia Treatment.
Immunoblot was performed for p-AMPK protein determination. p-AMPK protein was activated in
trophoblast cells exposed to either 16 mM glucose or hypoxia. Representative data are shown with *P ≤
0.05 when compared to controls.
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Table 3.1: Demographical Data from Collected Placental Samples.
Parameters between control and disease placental groups (n = 6) were analyzed for statistical significance
(p<0.05) using the Kruskal-Wallis test.
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Abstract
The Pyruvate kinase isozymes M2 (PKM2) protein is a metabolic enzyme that
regulates the final step of glycolysis. This enzyme is present in highly proliferating cells and
is expressed in the placenta. We recently demonstrated upregulated placental PKM2 during
human intrauterine growth restriction (IUGR). Our current objective was to determine
PKM2 regulation of trophoblast invasion, trophoblast PKM2 localization as well as mTOR
protein expression, and to determine effects of activation of PKM2 during IUGR. Human
placental tissues were obtained and analyzed by immunohistochemistry and western blot.
Trophoblast cells were cultured in normoxic and hypoxic conditions and real time cell
invasion and PKM2 protein were determined during activation (Fructose-6-bisphosphate;
FBP6) or inhibition (Shikonin) of PKM2. In vivo studies determined the effects of PKM2
activation on placental and fetal weights. IUGR samples had elevated levels of p-PKM2.
Different trophoblast PKM2 localization and expression was observed during normoxia and
hypoxia. Decreased trophoblast invasion and PKM2 expression was observed during mTOR
inhibition. Protection from decreased placental and fetal weights was observed by PKM2
activation. We conclude that PKM2 regulates trophoblast cell invasion depending on its
subcellular location. Our results suggest that PKM2 regulation in trophoblast cells is more
directly affected during hypoxia and its expression is regulated by mTOR activity.
Additionally, we conclude that activation of PKM2 could reverse and/or rescue the deceased
placental and fetal weights observed during IUGR. These results suggest that PKM2 could
be a mediator of trophoblast cell invasion and its abundance influences the development of
complicated pregnancies like IUGR.
Keywords: placenta, PKM2, mTOR, trophoblast invasion, hypoxia
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Introduction
In order to have a successful pregnancy, proper oxygenation of the placenta and fetus is
essential (Huppertz, 2014). Studies have shown that when a fetus experiences hypoxic stress, its
cardiac output is redistributed toward the heart and the brain at the expense of other organs. This
circulatory effect may lead to metabolic and cardiovascular disturbances later on in
adulthood (Ahmed, 2014; Bourque et al., 2012; Denton et al., 2015; Giussani & Davidge,
2013; Iqbal & Ciriello, 2013; Matheson et al., 2016; Myatt, 2006; Rueda-Clausen et al.,
2014). Adequate oxygenation is important for metabolic efficiency in placental tissue as the
placental trophoblasts mediate processes that require high energy consumption such as nutrient
transfer, synthesis of hormones and secretion of molecules (Bahr et al., 2014). Changes in supply
of nutrients to the fetus can affect its growth and development leading to obstetric complications
such as intrauterine growth restriction (IUGR) (Cetin & Antonazzo, 2009). Local hypoxia has
been thought to play an important role during IUGR. Normally, the uterine spiral arteries are
characterized as high resistance and low-capacity vessels. During pregnancy, endovascular
trophoblasts invade and replace the maternal endothelial cells that line the spiral arteries,
modifying these arteries into high capacity and low resistance vessels to meet increased blood
flow demands (Knuth et al., 2015; PIJNENBORG et al., 1991). During IUGR, shallow
trophoblast invasion fails to convert uterine spiral arteries into high capacity and low resistance
vessels, which leads to decreased blood flow and local hypoxia (Knuth et al., 2015;
PIJNENBORG et al., 1991). This insufficient modification of the arteries stemming from
shallow invasion reduces oxygen levels and nutrient supply and further affects placental
metabolism during IUGR. As such, placental metabolic adaptions are particularly important in
allowing the cells to meet ATP demands in the face of altered oxygen or substrate supply (Tissot
Van Patot et al., 2010). This underscores an important role for placental metabolism in placental
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growth and in the onset of obstetric complications such as IUGR.
An important enzyme involved in metabolism is Pyruvate Kinase M2 (PKM2). PKM2 is
a metabolic enzyme that transits between a less active dimer and an active tetramer that catalyzes
the last and rate-limiting reaction in the glycolytic pathway. These different forms of PKM2
regulate glucose metabolism through either dimeric PKM2 mediated aerobic glycolysis or
tetrameric mediated oxidative phosphorylation. The balance between the two forms is achieved
through the allosteric PKM2 regulation by fructose-1, 6-bisphosphate (FBP). Essentially, FBP,
an early glycolytic intermediate, binds to PKM2 and converts it from the less active dimeric form
with lower affinity for its substrate(s) to an active tetrameric form with higher substrate affinity
(Mazurek, 2011; Mazurek et al., 1997). When glucose is abundant, FBP levels increase and
PKM2 is activated, leading to TCA cycle progression. The disassociation of FBP converts
PKM2 to the dimeric form which promotes aerobic glycolysis, converting pyruvate to lactate for
energy production (Bahr et al., 2014). The PKM2 dimer activity results in the accumulation of
glycolytic intermediates that are involved in the synthesis of nucleic acids, amino acids, and
lipids ( G u p t a & B a m e z a i , 2 0 1 0 ) . Dimeric PKM2 can also enter the nucleus to regulate
gene expression and can play an important role in invasion and cell proliferation by diverting
glycolytic intermediates that accumulate in various biosynthetic path- ways (Zhang et al., 2019).
The transition between dimeric and tetrameric forms of PKM2 can play an important role in
tumor cell energy supply, epithelial–mesenchymal transition (EMT), invasion and metastasis
and cell proliferation. Shikonin is a natural product with therapeutic effects ranging from
anti-inflammatory, anti-oxidant, and anti-cancer due to inhibition of dimeric PKM2 activity
(Zhao et al., 2018). Inhibiting PKM2 by Shikonin suppresses cell glycolysis and invasion
while promoting apoptosis.
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An important regulator of cell growth is the mammalian target of rapamycin (mTOR)
protein (Jansson et al., 2006; Wullschleger et al., 2006). mTOR is a phosphatidylinositol kinaseregulated protein kinase that regulates cell growth in response to the availability of nutrients and
growth factors. Previous studies have shown a direct correlation between mTOR activation and
trophoblast invasion (Knuth et al., 2015). Furthermore, mTOR is known to regulate the
expression of PKM2 protein suggesting a role for PKM2 during placental trophoblast invasion
(Sun et al., 2011; Wong et al., 2013).
Based on roles of PKM2 in cell invasion and embryonic tissues, and the association of
shallow trophoblast invasion with IUGR pregnancies, we wanted to determine the role of PKM2
and mTOR in the invasion of trophoblast cells (Bahr et al., 2014). This included assessing
nuclear and cytosolic extracts of the trophoblast samples and identifying the invasive properties
of these cells. Investigating the role of PKM2 and the mTOR pathway in relation to trophoblast
invasion will provide valuable insight into IUGR pathology.
Materials and Methods
Human Placental Tissues
All frozen human term placental samples and slices (IUGR and Control) were purchased
from the Research Center for Women’s and Infant’s Health BioBank, Ontario, Canada. In total
there were 10 samples analyzed for each control and disease group. Samples were collected
from placentas delivered in conjunction with delivery of the fetus either vaginally or by Csection. Sample demographics are shown in Table 1.
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Immunohistochemistry
Immunohistochemistry was performed as previously outlined in our lab (Arroyo et al.,
2010). Briefly, slides were de-waxed, washed in a 1x Tris buffer solution (TBS), and blocked
with Background Sniper (Biocare Medical, #BS966H, Concord, CA) for 1 h. This was
followed by incubation overnight with a primary antibody (PKM2-Cell Signaling Technology,
Danvers, MA, Cytokeratin 7-Dako, Carpinteria, CA, mouse (for trophoblast localization). Slides
were then incubated for 1 h with Mach 2 Universal HRP Polymer Detection (Biocare Medical,
Concord, CA), followed by color development with diaminobenzidine (DAB) for 5 min (Biocare
Medical, Concord, CA). A 5 s Hematoxylin soak was used for nuclear counterstain. Slides were
washed 3x for 5 min in TBS between each step. Slides were mounted using Permount media.
Cell Culture
An immortalized first trimester trophoblast Swan71 cell line (SW71) was used in this
study. The SW71 cell line was a generous gift from Dr. Gil Mor at Yale University
(Straszewski-Chavez et al., 2009). Cells were trophoblast maintained and cultured in RPMI
medium (Mediatech, Manassas, VA) supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin and streptomycin. Cells were plated and treated in 6 well plates and used for protein
analysis.
Cell T reatments
Control cells were incubated in media alone (n=10); the first group of experimental cells
were treated with media supplemented with 100 nM of fructose 1,6-biphosphate (n=10; FBP6,
an PKM2 activator; R and D Systems, Minneapolis, MN), a second group of experimental cells
were treated with media supplemented with 1 μm of Shikonin (n=10; PKM2 inhibitor;
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Selleckcheme, Houston, TX), and a third group of experimental cells were treated with media
supplemented with 40 nM of Rapamicin (n 10; mTOR inhibitor; Selleckcheme, Houston, TX.
Treatments were conducted for 24 h. Cells were then detached using Trypsin EDTA (0.05%;
Thermo Fisher, Waltham, Massachusetts) for invasion analysis or lysed used RIPA buffer
(Thermo Fisher) for immunoblotting studies.
Cytoplasmic and Nuclear Extraction
Placental and trophoblast cells were lysed were in a microcentrifuge tube with 500 μL of
(ice cold) CER I, and 5 μL of protease inhibitor (Thermo Scientific, Rockford, IL). The rest of
the protocol was followed in accordance with the NE-PER Nuclear and Cytoplasmic Extraction
Reagents kit (Thermo Scientific, Rockford, IL) using 27.5 μL of (ice cold) CER II and 125 μL
of ice-cold NER with1.25 μL of protease inhibitor (Thermo Scientific, Rockford, IL).
Supernatants were collected into clean, chilled, pre-labeled microcentrifuge tubes and kept on
ice. To determine protein concentrations, cytoplasmic and nuclear supernatants were analyzed
with a Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL). Briefly, 2 μL of
each sample was combined with 150 μL of Reagent A and B (50:1) in a labeled 96 well plate.
The plate was covered and incubated at 37 ◦C for 20 min, cooled to RT, and read on a
SpectraMax 340 PC absorbance microplate reader (Molecular Devices, Sunnyvale, CA).
Samples were run in duplicate, averaged, and compared to a bovine serum albumin standard
curve. Supernatants, in micro- centrifuge tubes, were stored at 80 ◦C for future use.
Cytosolic and nuclear extract purity was determined by western blot analysis using lamin B 1
and beta actin antibodies.
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Western Blotting
Whole tissue lysates (50 μg) or cytoplasmic and nuclear lysates (50 μg) were separated
on a 10% SDS-Page gel and transferred onto nitrocellulose membranes. The membranes were
blocked for 1 h followed by overnight incubation with primary antibodies (p-PKM2 and PKM2,
Cell Signaling Technology, Danvers, MA; mTOR; 1:200; Cell Signaling Technology, Danvers,
MA). Membranes were then incubated with secondary IRDye antibodies (1:10,000, 680RD
donkey-anti goat and 680RD donkey-anti rabbit; LI-COR Lincoln, NE) at room temperature
for an hour. Membranes were finally developed on a Li-COR Odyssey CLx. All results were
normalized to Lamin B1 or B actin (Santa Cruz Biotechnology, Dallas). Fluorescence densities
were determined, and comparisons were made between treated and control groups.
Real Time Cell Invasion Determination
Real time cell invasion was performed as previously described (Aagaard et al., 2017).
Briefly, additional cell cultures were conducted, and invasion was assessed in 16 well-CIMPlates (n 9; ACEA Biosciences, San Diego, CA). These plates are composed of an upper
chamber coated with type IV collagen (1:40; Corning, Corning, NY) and a lower chamber
with 10% FBS RPMI. Cells were plated in the top chamber at a concentration of 20, 000
cells/well in 2% FBS RPMI in a total volume of 100 μL in the presence FB6 or Shikonin. The
cells were then placed in the RTCA DP instrument and invasion readings were taken every 15
min for 24 h.
Animals and Tissue Preparation
Animal use was approved by the Institutional Animal Care and Use Committee at
Brigham Young University. C57 Black 6 (C57BL/6) mice were purchased from Charles River
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laboratories, Wilmington, MA. To obtain timed pregnancies, females were caged with males
overnight. Placentae and mesometrial compartments were dissected from pregnant mice at 18.5
days of gestation (dGA). Placentae and fetuses were weighed, and tissues were snap frozen in
liquid Nitrogen for RNA and protein analysis. Whole conceptuses were frozen in dry ice-cooled
heptane for immunohistochemistry analysis. All tissue samples were stored at
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used. Secondhand Smoke (SHS) and PKM2 activator Treatment. The generation of thane
IUGR pregnancy occurred following expo- sure of pregnant mice (n 7) to SHS conditions as
previously shown by Winden et al. (Winden et al., 2014) Pregnant mice were placed in the noseonly Scireq InExpose cigarette-smoking robot starting at day 14.5 dGA and exposed for four
days with necropsy at 18.5 dGA. IUGR was induced following 4 days of exposure wherein a
computer-controlled puff of smoke generated every minute resulted in 10 s of SHS exposure
(from six cigarettes; 2R1, University of Kentucky, Lexington, KY) followed by 50 s of rom air
(fresh air). This procedure was done daily for 10 min during the time of treatment. Control
animals (n 7) were place in soft restrains and exposed only to room air daily for 10 min. For
PKM2 activation studies the SHS treated animals were treated with 50 mg/kg of TEPP-46 PKM2
activator (Millipore, Saint Louis, MO) from 11dGA through necropsy at 18dGA ( A ngi a ri e t
a l . , 2 0 2 0 ; Le e t a l ., 2020) . At this point, placental and fetal weight were recorded for in
vivo studies.
Statistical Analysis
Control and IUGR placentas and cell protein lysates end points were compared for
PKM2. Data was analyzed for normality and differences using the Mann-Whitney test with p <
0.05 as significantly different. Table 1 was analyzed with the Kruskal-Wallis test for statistical
significance with p < 0.05 as statistically significant. All data represent the mean ± SEM.
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Results
Placenta Demographics
Human placenta sample demographics were analyzed for significant differences between
Control and IUGR groups. There was no difference in maternal age. IUGR groups had
statistically lower (p < 0.0003) gestational ages compared to controls. Fetal weights from IUGR
patients were also statistically lower (P < 0.0001) compared to the control group.
Placental PKM2 Expression During IUGR
We first wanted to determine PKM2 expression in human placenta tissues of normal
gestation and IUGR. IHC did not reveal differences in PKM2 expression in the villi of the
trophoblast cell in the IUGR placenta as compared to controls (Figure 4.1). No differences
were observed in cytosolic PKM2 protein expression between IUGR and control placentas
(Figure 4.1A–B). Elevated nuclear expression of PKM2 was detected in the IUGR placentas
(1.4-fold; p < 0.03) as compared to control placentas (Figure 4.1C).
PKM2 and Trophoblast Invasion
To determine PKM2 in SW71 trophoblast invasion, we first deter mined the localization
of PKM2 in these cells. Interestingly, we observed a higher expression of PKM2 in the nucleus
as opposed to the cytosol in SW71 cells (Figure 4.2A–B). We next determined cell viability
using the already published suggested concentration for Shikonin (1 μm–500 μm) and (100 nm–
250nm). We did not observe any differences in cell viability between the treated and control
cells (data not shown). To further characterize the role of PKM2 in trophoblast cell invasion,
we next investigated the effects of its activation/inhibition during the invasion of these cells.
We observed increased in trophoblast invasion (1.8-fold; p < 0.002) when PKM2 was
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activated (Figure 4.2C). In contrast, there was a significant decrease in trophoblast invasion (65fold; p < 0.002) when cells were treated with Shikonin (Figure 4 . 2C). These results
confirmed a role for PKM2 in the regulation of trophoblast invasion. Nuclear PKM2 is used as a
transcriptional regulator while cytosolic PKM2 predominantly functions as a glycolytic enzyme
(Bahr et al., 2014; Park et al., 2019). We next examined the nuclear and cytosolic PKM2
protein levels in the trophoblast cells treated with F1BP6 or Shikonin. We observed that both
pPKM2 and PKM2 were decreased in the cytosol (1.9-fold; 1.7-fold; p < 0.03) when Shikonin
was added to the cells while no differences were observed with F1BP6 treatment (Figure 4.3A–
B). In contrast, both pPKM2 (1.7-fold; 2.5-fold; p < 0.04) and PKM2 (1.7-fold; 1.8-fold; p <
0.004) were increased in the nucleus with treatment of F1BP6 or Shikonin when compared to
controls (Figure 4.3C–D). As previously mentioned, IUGR is associated with local hypoxia.
Therefore, we decided to examine trophoblast invasion and PKM2 levels in hypoxia treated and
normoxic trophoblast cells. Hypoxia treatment decreased trophoblast invasion for both F1BP6
(3.0-fold; p < 0.005) and Shikonin (55-fold; p < 0.005) treated trophoblast cells (Figure 4.4).
Cytosolic pPKM2 protein was only decreased with F1BP6 (2-fold; p < 0.03) when the cells
were exposed to hypoxia (Figure 4.5A). In contrast, cytosolic PKM2 protein was not changed
with either treatment during hypoxia (Figure 4.5B). In comparison, nuclear PKM2 was
decreased in both, F1BP6 (1.6-fold; p < 0.03) or Shikonin (1.9-fold; p < 0.03) treatment with
no differences for nuclear pPKM2 in the hypoxia treated trophoblast cells when compared to
controls (Figure 4.5C–D).
mTOR, PKM2 and Trophoblast Invasion
A role for mTOR in trophoblast invasion has been previously shown (Knuth et al.,
2015). Because PKM2 expression can be regulated by mTOR, we decided to determine if the
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impairment of mTOR affects PKM2 expression and leads to altered trophoblast invasion. For
these experiments, SW71 trophoblast cells were treated with 40 nm of Rapamycin for 24
h. Activation of mTOR was reduced (1.1-fold; p < 0.05) in treated cells as compared to control
(Figure 4.6A). Interestingly, PKM2 protein was also reduced in the treated trophoblast compared
to controls (Figure 4.6B). These results correlated with a reduction in invasion of treated
trophoblast cells (Figure 4.6C). To further confirm a correlation between mTOR and PKM2, we
inhibited PKM2 and measured pmTOR in trophoblast cells and observed decreased mTOR
activation when PKM2 was inhibited (Figure 4.6D).
PKM2 and IUGR
PKM2 is present in cancer cells and embryonic tissues. To better understand the role of
activated PKM2 in vivo, we decided to use the SHS induced IUGR model wherein placental and
fetal weights are compromised. TEEP46 is a PMK2 inhibitor successfully used in vivo
(Angiari et al., 2020; Le et al., 2020). We treated mice with both SHS and TEEP46, the
PKM2 activator, and assessed the outcomes of placental and fetal weights (Lewis et al.,
2017). There was a significant 28% reduction in placental weight (p < 0.0003) in SHS
exposed mice compared to room air controls. This reduction was improved when animals
were treated with SHS and TEEP46 (Figure 4.7A). Similarly, we demonstrated a 49%
reduction in fetal weight (p < 0.0002) in SHS exposed mice, which was recovered when SHS
animals were treated with the PKM2 activator (Figure 4.7B).
Discussion
The Pyruvate Kinase M2 (PKM2) enzyme is regulated by multiple signal pathways and
has been shown to have an important role in cancer cell metabolism and growth (Chen et al.,
2011; Wu & Le, 2013). Less active PKM2 inhibits overall glycolysis, but promotes aerobic
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glycolysis, converting pyruvate to lactate for energy production. The inhibition of glycolysis by
the less active dimer form of PKM2 allows redistribution of glycolytic intermediates to support
biosynthesis of macromolecules and cancer proliferation (Cairns et al., 2011; Christofk et al.,
2008). Although PKM2 in cancer cells has been studied, understanding of PKM2 in the placenta
and embryonic tissues is very limited. Previous studies in our laboratory demonstrated increased
nu- clear PKM2 in the IUGR placenta (Bahr et al., 2014). To confirm our previous results, we
performed IHC and western blot. We observed no differences when staining for PKM2 in the
IUGR placenta and control. Interestingly, we detected increased PKM2 protein in the nucleus of
the IUGR placenta by blotting. These results suggest that placental PKM2 localization could
play a role in IUGR disease progression and that its expression may be involved in the use of
alternative glycolytic pathways during this disease.
A hallmark of pregnancies associated with IUGR is shallow invasion of the trophoblast
cells and this shallow invasion is associated with local hypoxia and inhibition of trophoblast
invasion (Knuth et al., 2015). We first wanted to determine the expression of PKM2 in the
invasive trophoblast cells. We observed that PKM2 was mostly expressed in the nucleus of these
cells. Previous reports established a role for PKM2 as a nuclear transcription factor (Yang et al.,
2011, 2012). Our results suggest that PKM2 in these cells could potentially have a bigger role as
a transcription factor in addition to effecting other signaling transduction processes. Because of
the high PKM2 expression in these invasive cells, we sought to determine the role of PKM2
activation and the invading properties of these trophoblast cells. Interestingly, our studies
showed that trophoblast invasion was regulated by the activation of this enzyme. These results
portend that perhaps levels of PKM2 activation could be a factor involved in the regulation of
trophoblast invasion during pregnancy. Previous reports showed that phospho PKM2 (pPKM2)
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can act as a transcription factor in tumor cells (Hitosugi et al., 2009; Yang et al., 2011,
2012, 2014). We looked at the cytosolic and nuclear expression of PKM2, p-PKM2 in
control and treated cells. Trophoblast cells treated with Shikonin experienced decreased
cytosolic expression of both pPKM2 and PKM2 while their expression was increased in the
nucleus of these cells. This set of observations support the idea that PKM2 dimer inhibition
leads to an increased role for PKM2 as a transcription factor, and a shift from the TCA cycle to
the less effective aerobic glycolysis under minimum environmental stress may result in
decreased cell invasion (Zhang et al., 2019). Interestingly, we observed no differences in
cytosolic pPKM2 and PKM2 while there was increased nuclear expression during FBP
treatment. This was unexpected as we suspected cytosolic PKM2 to be increased. Although
nuclear expression of PKM2 was increased, the increase was higher for PKM2 than for
pPKM2. This may mean that PKM2-mediated transcriptional control is lower during PKM2
activation by FBP. Collectively, these results suggest alternative regulation for PKM2
localization during its activation or inhibition.
As previously mentioned, pregnancies complicated by IUGR are characterized by the
development of hypoxia and shallow trophoblast invasion. Our results showed decreased
trophoblast invasion with either FBP or Shikonin treatment in the hypoxia treated cells.
Decreased invasion in the FBP treated samples confirmed the role of FBP in stabilizing
tetrameric PKM2 and the oxidation phosphorylation pathway. This paradigm reduces
metabolic efficiency under hypoxia conditions leading to the reduction in trophoblast invading
ability. Trophoblastic invasion was further potentiated with the dimeric PKM2 mediated
aerobic glycolysis inhibition by Shikonin. Interestingly, we detected decreased cytosolic
pPKM2 but not PKM2 when trophoblasts were treated with FBP. In contrast, cytosolic PKM2
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was only increased with Shikonin treatment of these cells. In the nuclear fractions, only PKM2
was changed (decreased) with either treatment. These results suggest a separate signaling
pathway controls PKM2 regulation during hypoxia treatment. Because regulation of PKM2
expression and previous observations that placental mTOR was decreased during IUGR, we
wanted to determine if there was a correlation between these molecules in trophoblast cells
during IUGR (Arroyo et al., 2009; Kimball et al., 2015; Mejia et al., 2017). Using Rapamycin
as an mTOR inhibitor, we detected decreased mTOR activation and that the decrease correlated
with diminished PKM2 expression and hindered trophoblast invasion. To further confirm
mTOR and PKM2 correlation, we showed that mTOR expression decreases by Shikonin
inhibiting action on PKM2 in the trophoblasts. These suggest roles for both molecules in the
regulation of trophoblast invasion.
PKM2 is increased in embryonic tissues, and its abundance is likely supportive of the
rapid growth and development required during pregnancy (Dombrauckas et al., 2005). To
further describe the role of PKM2 activation during pregnancy, we determined the impact of
PKM2 activation on compromised placental and fetal weight during IUGR. We observed
decreased placental and fetal weight in our model of IUGR that was recovered with cotreatment of a PKM2 activator. These targeting studies suggest an important role for PKM2
activation and foretells avenues that could be beneficial for the development of possible
therapies during disease associated with compromised placenta and fetal weights including
IUGR.
In conclusion, PKM2 appears to be an excellent candidate of study in understanding
metabolic differences and their effects during trophoblast invasion. It is currently unclear if
PKM2 activity in human placentas serves as a primary or secondary regulator of placental
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metabolism. However, our results suggest that perhaps, similar to what is suggested in cancer
cells, PKM2 expression could serve as a secondary effect to hypoxia in the placenta (Tal et al.,
2010). Future studies are needed to better understand the role of PKM2 during the development
of the placenta throughout gestation.
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Figure 4.1: Placental PKM2 Expression During IUGR.
IHC staining showed no differences in PKM2 expression (DAB, brown) in the villi of trophoblast
cells (Hematoxylin counterstain, blue) between normal gestation control and IUGR (A-B).
Subcellular quantification of protein expression showed no difference in the cytosolic expression of
PKM2 between IUGR and control samples (C), while elevated nuclear expression was detected in
the IUGR placenta compared to controls (D). Data are shown with *P ≤ 0.05 compared to controls.
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Figure 4.2: PKM2 and Trophoblast Invasion.
PKM2 was predominantly present in the nucleus compared to the cytosol of SW71 trophoblast cells.
(A-B). Trophoblast invasion was increased (1.8-fold; p < 0.002) during PKM2 activation through
FBP6 treatment, while the invading event was decreased (65-fold; p < 0.002) during PKM2
inhibition by Shikonin (C). Data are shown with *P ≤ 0.05 compared to controls.
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Figure 4.3: Subcellular PKM2 and p-PMK2 Expression.
Cytosolic expression of p-PKM2(A) and PKM2 (B) was decreased (1.9-fold; 1.7-fold; p < 0.03)
when treated with Shikonin. No significant differences in p-PKM2 or PKM2 were detected when
trophoblast cells were treated with FBP6 compared to controls (A-B). p-PKM2 (1.7-fold; 2.5-fold; p
< 0.04) and PKM2 (1.7-fold; 1.8-fold; p < 0.004) nuclear expression were significantly increased
with FBP6 or Shikonin treatment compared to controls (C-D). Data are shown with *P ≤ 0.05
compared to controls.
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Figure 4.4: PKM2 and Hypoxic Trophoblast Invasion.
Hypoxia treatment decreased trophoblast invasion in both FBP6 (3.0-fold; p < 0.005) or Shikonin
(55-fold; p < treated trophoblast cells. Data are shown with *P ≤ 0.05 compared to controls.
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Figure 4 .5: Subcellular PKM2 and p-PKM2 Expression
In Hypoxic Trophoblasts. Cytosolic expression of p-PKM2 was decreased (2-fold; p < 0.03) in FBP6
treated hypoxic cells (A), while PKM2 showed no significant difference with either treatment relative
to controls (B). Nuclear PKM2 was decreased in both, FBP6 (1.6-fold; p < 0.03) or Shikonin (1.9fold; p < 0.03) treatment with no differences for nuclear pPKM2 (C) in the hypoxia treated
trophoblast when compared to controls (C-D). Data are shown with *P ≤ 0.05 compared to controls.
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Figure 4.6: mTOR, PKM2 and Trophoblast Invasion.
mTOR inhibition by Rapamycin treatment resulted in reduced mTOR activation (1.1-fold; p < 0.05)
compared to controls (A). PKM2 protein was reduced (p < 0.05) when treated with Rapamycin
compared to controls (B). Trophoblast invasion was decreased (p < 0.05) when mTOR was inhibited
by Rapamycin (C). mTOR activation was reduced when PKM2 was inhibited by Shikonin treatment
(D). Data are shown with *P ≤ 0.05 compared to controls.

Figure 4.7: PKM2 Effect on Placental and Fetal Weights in a SHS Induced IUGR Model.
A significant 28% reduction in placental weight (p < 0.0003) was observed in the SHS mice
compared to controls, while the reduction was improved by treatment of TEEP46, a PKM2 activator
(A). SHS induced a significant 49% reduction in fetal weight (p < 0.0002) that was recovered with
TEPP46 treatment during SHS (B). Data are shown with *P ≤ 0.05 compared to controls.
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CHAPTER 5: General Discussion
Inflammatory Pathologies of Pregnancy Complications
To accommodate the appearance of a foreign body, pregnancy is either a proinflammatory or an anti-inflammatory condition. Thus, the regulation of inflammation is directly
associated with pregnancy outcomes. RAGE-mediated inflammatory response has been
recognized as a significant cause of diseases and can be triggered by infections, trauma, toxins,
and genomic instability. Expectedly, RAGE has been shown to mediate pregnancy complications.
In concordance with this, previous studies in our laboratory showed increased placental RAGE
during obstetric complications.
The other event that links RAGE mediated inflammatory response is DNA damage such
as previously reported in neuropathy and pulmonary diseases. Though a pattern of DNA damage
has been reported in pathological placentas, its impact on pregnancy is still unknown. However,
the newly reported nuclear isoform of RAGE provides a link between inflammation and DNA
damage in the placenta. The current work demonstrates the involvement of RAGE during
placental DNA-DSB repair. We identified the presence of DSB in preeclampsia and preterm labor
and the involvement of RAGE in the DSB repair process through its conjugation with ATM and
MRN complex. Similar results were observed when DNA damage was induced in trophoblast
cells by cigarette smoke or bleomycin treatment. Additionally, examination of trophoblastic
functions revealed the negative impacts of genomic instability on trophoblast invading function
which is associated with the development pregnancy complications. These outcomes confirm the
implications of RAGE in maintaining genomic integrity in the placenta and suggest a role for
genome defect in the pathologies of pregnancy complications.
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Altered Signaling in Obstetric Pathologies
Along with inflammation, alterations of other signaling pathway have also been known of
its contribution to pregnancy complications example such as mTOR and PKM2 metabolic
signaling cascade.
mTOR is also important for regulating energy homeostasis through its interplay with
AMPK which exerts opposite actions. Our studies observed elevated levels of mTOR during
nutrient abundant GDM placenta and decreased of mTOR during limited nutrient conditions of
PE and IUGR. Surprisingly, AMPK was found elevated in both GDM and PE. mTOR also
regulates energy availability through mediating PKM2. In our studies, the activation of PKM2
was decreased by inhibiting mTOR through rapamycin treatment. PKM2 positively regulates
trophoblast invasion, and this effect was diminished under hypoxia condition which mimics
IUGR. Furthermore, the addition of PKM2 activator rescue placental and fetal weight from SHS
treatment in rodents. Thus, understanding the metabolic differences of mTOR and PKM2 and
their effects during trophoblast invasion allows better insights for placental and fetal
developments.
Future Directions
Through exploring the implications of RAGE, mTOR, and PKM2 during pregnancy, we
uncovered the fundamental regulations of inflammation and metabolism during placental and
fetal developments. Our research primarily focused on the related molecules and the downstream
signaling cascades of these pathways. Our research and several lines of study suggest the
interplay of the inflammatory and metabolic pathways. Further evaluation of the interplay
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between inflammatory and metabolic pathways in individual pregnancy complications will allow
better insights for pathologies and disease development and can lead to new avenues that may
help alleviate diseases associated with pregnancy complications.
Relevance of Research
Study of pathologies bridges basic research and medicine by enhancing the translational
value of the research. This can be beneficial in disease prevention, diagnosis, treatment, and
post-treatment care. Though advanced knowledge is constantly uncovered through continuous
research, there remains many unexplored pathological pathways especially in the reproductive
field. Our work provides understanding in the contribution of inflammatory and the altered
signaling pathways and lays a foundation for further investigation on the pathological signaling
pathways associate with pregnancy complications. Understanding these mechanisms provide
significant insights into broad swaths of biology with far-reaching biomedical relevance in care
of patients with obstetric complications.
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Abstract
Tobacco exposure is one of the top three global health risks leading to the development
of chronic obstructive pulmonary disease (COPD). Although there is extensive research into the
effects of cigarette smoke, the effect of secondhand smoke (SHS) in the lung remains limited.
SHS induces receptors for advanced glycation end-products (RAGE) and an inflammatory
response that leads to COPD characteristics. Semi-synthetic glycosaminoglycan ethers (SAGEs)
are sulfated polysaccharides derived from hyaluronic acid that inhibit RAGE signaling. The
growth arrest-specific 6 (Gas6) protein is known to induce dynamic cellular responses and is
correlated with cell function. Gas6 binds to the AXL tyrosine kinase receptor and AXL-mediated
signaling is implicated in proliferation and inflammation. This project's purpose was to study the
correlation between RAGE, AXL, and Gas6 during SHS exposure in the lung. C57Bl/6 mice
were exposed to SHS alone or SHS + SAGEs for 4 weeks and compared to control animals
exposed to room air (RA). Compared to controls we observed: 1) increased RAGE mRNA and
protein expression in SHS-exposed lungs which was decreased by SAGEs; 2) decreased
expression of total AXL, but elevated pAXL expression; 3) highly elevated Gas6 expression
when RAGE was targeted by SAGEs during SHS exposure; 4) SHS-mediated BALF cellularity
and inflammatory molecule elaboration; and 5) the induction of both RAGE and AXL by Gas6
in cell culture models. Our results suggest that there is a possible correlation between RAGE and
AXL during SHS exposure. Additional research is needed to dissect the molecular interplay
between these two important signaling cascades. At this point, studies provide insight into
tobacco-mediated effects in the lung and clarify possible avenues for alleviating complications
that could arise during SHS exposure such as those observed during COPD exacerbations.
Keywords: RAGE, AXL, tobacco, lung, inflammation
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Introduction
Tobacco smoke contains over 4000 chemical substances (Moritsugu, 2007), and classes
of these entities have been experimentally correlated with adverse health outcomes. The
combustion of tobacco products produces a diversity of compounds observed in both gaseous
and particulate fractions. Many of these compounds are toxic components that induce
inflammation and cause irritation. A common development of prolonged smoke exposure is
chronic obstructive pulmonary disease (COPD), one of the leading causes of mortality and
morbidity and currently estimated to affect roughly 5% of the world’s population or about 329
million individuals (World Health Organization, 2011). The data overwhelmingly implicate
active smoking as the greatest risk factor for developing COPD (Hagstad et al., 2014); however,
exposure to secondhand smoke (SHS) is also associated with risk for COPD (Hagstad et al.,
2014). Globally, COPD is projected to be the third leading cause of death by 2020. Economists
have estimated that the economic burden (including both direct and indirect costs) resulting from
COPD was $2.1 trillion in 2010; however, they believe it will rise to $4.3 trillion by 2030
(Lomborg, 2013). Direct costs alone have been estimated to be in the $49.9 billion range,
suggesting a greater need for preventative measures, as well as improvements in earlier diagnosis
and more cost-effective treatment. Critically necessary in developing therapeutics that aid
affected individuals is the need to more fully understand underlying molecular mechanisms that
promulgate inflammatory stress. The current undertaking sought to identify possible interplay
between two smoke-induced progression factors that act as receptors for pro-inflammatory
stimuli: receptors for advanced glycation end-products (RAGE) and AXL receptor tyrosine
kinases (AXL). RAGE is a cell-surface receptor of the immunoglobulin superfamily expressed in
many cell types including endothelial and vascular smooth muscle cells, fibroblasts,
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macrophages/monocytes, and epithelium (Thornalley, 1998). RAGE is abundantly expressed by
well-differentiated pulmonary alveolar type I (ATI) epithelial cells (Schmidt & Stern, 2000).
RAGE was first described as a progression factor in cellular responses induced by irreversibly
glycated proteins called advanced glycation end-products (AGEs) and cigarette smoke is an
important exogenous inducer of AGE formation (Cerami et al., 1997; Nicholl & Bucala, 1998).
RAGE has also been distinguished as a pattern recognition receptor that binds S100/calgranulins,
amyloid--peptide, and HMGB-1 to influence gene expression via activated signal transduction
pathways (Hofmann et al., 1999; Taguchi, Blood, Del Toro, & Canet, 2000; Yan et al., 1996).
Specifically, a host of pro-inflammatory responses such as those coordinated by MAP
kinases, NF-κB, reactive oxygen species (ROS), and other pro-inflammatory mediators such as
TNF and IL-1 (Sparvero et al., 2009) result from RAGE-ligand interactions. In contrast to shortlived cellular activation by LPS, engagement of RAGE by its ligands results in prolonged
inflammation (Schmidt, Yan, Yan, & Stern, 2001). If left unchecked, such chronic inflammation
results in severe tissue injury.
Abrogation of RAGE signaling using Rage knockout mice attenuated elastase-induced
emphysema (Waseda K, 2015) and significantly protected against smoke-induced airway
inflammation and emphysema (Li et al., 2015; Sambamurthy, Leme, Oury, & Shapiro, 2015).
Soluble RAGE (sRAGE) was identified as a serum biomarker in tomography assessed
emphysema (Carolan BJ, 2014) and its ratio to RAGE ligands was a good predictor of COPD
status (Zhang Y, 2014). A link between RAGE and COPD was further supported by data that
implicated RAGE polymorphisms in COPD progression (Li Y, 2014). Previous mouse studies in
our lab led to discoveries that smoke exposure increased RAGE signaling both in vitro and invivo
(Reynolds et al., 2008; Winden DR, 2014; Wood TT, 2014). Together, these studies demonstrate
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that RAGE is a key modulator of inflammation in major lung diseases, and up- regulation in
lungs exposed to chronic smoke strongly suggests RAGE may play an importantrole in COPD.
AXL is a receptor tyrosine kinase (RTK) that is documented to function in diverse
cellular processes such as proliferation, migration, survival, and metabolism (Brunelleschi,
Penengo, Santoro, & Gaudino, 2002). Like family members Tyro3 and Mer, AXL is a
transmembrane receptor with two immunoglobulin-like motifs in its extracellular domain that
catalyzes kinase reactions (Mark et al., 1994). The vitamin K-dependent protein Gas6 is AXL’s
most common ligand, and both are widely expressed by lungs, intestine, vascular epithelium,
andplacenta (Manfioletti, Brancolini, Avanzi, & Schneider, 1993). Following ligation, AXL
signaling results in phosphorylation of cytoplasmic substrates including PI3K, Akt, Src Kinase,
ERK, p38, STATE3 and NF-κB (Allen et al., 1999; Fridell et al., 1996; Goruppi, Chiaruttini,
Ruaro, Varnum, & Schneider, 2001; Guttridge et al., 2002). It was recently discovered that
serum levels of AXL is significantly higher in patients with COPD compared to other patients
and that the presence of AXL likely influences COPD prognosis (Berg et al., 2018). Gao et al.,
recently reported that prenatal tobacco smoke establishes increased risk for asthmatic episodes
and other acute exacerbations (Gao, Liu, et al., 2018), supporting other research into the
blockade of AXL signaling and resulting amelioration of pulmonary inflammation and airway
hyperresponsiveness (Shibata et al., 2014). It is assumed that AXL signaling is a negative
regulator of pulmonary epithelial structure and function and that diminished AXL activity
correlates with better epithelial barrier integrity, decreased cellular mobility, and less
pathological remodeling (Fujino, Kubo, & Maciewicz, 2017).
Due to clearly identified functions of both RAGE and AXL during smoke exposure, a
more lucid understanding of their contributions to the inflamed lung is needed. The current
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research sought to identify the expression of both receptors during smoke exposure and evaluate
potential effects in orchestrating an inflammatory response. We specifically evaluated the
expression profile of these receptors in the SHS-exposed mouse lung and related markers of
inflammation in an established mouse model of smoke exposure (Joshua B Lewis et al., 2017;
Joshua B. Lewis et al., 2017; Reynolds et al., 2008; Robinson, Stogsdill, Lewis, Wood, &
Reynolds, 2012; Winden et al., 2014; Wood et al., 2014). We then correlated the inducibility of
both receptors in an in vitro system involving A-549 cells, an alveolar type II-like epithelial cell
line. Future directions should more clearly evaluate the combined functions of both signaling
cascades and determine to what extent, if any, they cooperate in the progression of inflammatory
disease.
Materials and Methods
Mice and Tissue Preparation
Adult C57Bl/6 mice were exposed to secondhand tobacco smoke (SHS) or room air (RA)
for five days a week and over a course of four weeks as already outlined (Winden et al., 2013).
Briefly, mice (n=8 per group) were randomly assigned to RA- and SHS-exposure groups and
treated using an in-house nose-only smoke exposure system (InExpose System, Scireq, Canada).
Treated mice were restrained daily and connected to an exposure tower for 10 minutes where
they were nasally exposed to SHS from two standard research cigarettes for five days a week and
over a course of four weeks (Wood TT, 2014). The SHS challenge for these studies was chosen
according to previously published literature and was associated with a good tolerance of mice to
the SHS sessions and an acceptable level of particulate density concentration (Reynolds et al.,
2008; Rinaldi et al., 2012). Control animals were similarly handled and restrained but kept in a
smoke-free environment. Where indicated, mice were also administered via i.p. injection a bolus
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of 30 mg/kg (three days a week for four weeks) of inflammation modulating sulfated
polysaccharides derived from hyaluronic acid (HA) called semi-synthetic glycosaminoglycan
ethers (SAGEs). SAGEs were a gift from Dr. Glenn D. Prestwich from the University of Utah
and they potently prevent RAGE-ligand binding at nanomolar concentrations (Zhang et al.,
2011). At the conclusion of the exposure, mice were sacrificed, and lungs were inflation fixed
with 4% paraformaldehyde for immunofluorescent studies, lavage to procure bronchoalveolar
lavage fluid (BALF) (Stogsdill et al., 2013) or resected prior to the isolation of total protein or
RNA (Reynolds, Mucenski, Le Cras, Nichols, & Whitsett, 2004; Stogsdill et al., 2013). The
Institutional Animal Care and Use Committee (IACUC) at Brigham Young University approved
mice use.
Cell Culture
Human alveolar type II–like pulmonary adenocarcinoma cells (A549; ATCC, Manassas,
VA) were maintained in DMEM supplemented with 10% FBS and antibiotics (Mediatech;
Manassas, VA). Cells were split into 6-well dishes and grown to 40–50% confluence. A549
cultures were exposed to normal media or media supplemented with Gas6 (R&D, Minneapolis,
MN) at a concentration of 600 ng/mL with or without 600 ng/mL R428 (APExBIO, Houston,
TX), a commercially available AXL inhibitor. Total protein was isolated after 24 hours. In vitro
experiments were performed at least twice in triplicate and representative data are shown.
Immunofluorescence
Immunofluorescence (IF) was performed as previously performed in our laboratory
(Jimenez et al., 2015). In summary, slides were blocked with Sniper (Biocare Medical, Concord,
CA) and incubated overnight with a mouse primary antibody against RAGE (R&D Systems,
Minneapolis, MN; Cat# mAb1179, 1:300), AXL (Cell Signaling, Cat#8661S, 1:300), pAXL
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(Cell Signaling, Cat# 5724S, 1:200), or Gas6 (R&D Systems; Cat# AF885-SP, 1:200). Slides
were incubated for an hour with a donkey anti-mouse Texas Red (TX) (Santa Cruz
Biotechnology, Santa Cruz, CA). Staining experiments included a no primary control in which
sections were treated identically to the others with the exception that slides were incubated with
serum that lacked primary antibody Immunofluorescence was detected using a BX6 microscope.
Immunoblotting
Immunoblotting was performed as previously outlined by our laboratory (Winden DR,
2014). Briefly, tissues were homogenized in protein lysis buffer (RIPA, Fisher Scientific,
Pittsburg, PA). 20 µg of protein lysates were separated on Mini-PROTEAN® TGX™ Precast gel
(Bio-Rad Laboratories, Hercules, CA) and transferred to nitrocellulose membranes. Membranes
were blocked and incubated with polyclonal antibodies against RAGE (R&D Systems; Cat#
mAb1179 at a dilution of 1:250) or total or phospho AXL (pAXL) (Cell Signaling; Danvers,
MA, cat# 5724S, 1:250). Secondary fluorescence tagged antibodies were added for one hour at
room temperature. Fluorescence emission was digitally recorded using a C-DiGit® Blot Scanner
(LI-COR, Inc., Lincoln, Nebraska). To determine loading consistencies, each membrane was
stripped from antibodies and re-probed utilizing an antibody against actin (Cell Signaling; cat#
4967L, 1:500). Immunoblotting was conducted at least twice in triplicate and average band
densities were normalized to β-actin densities prior to performing statistical tests.
RNA Isolation and Analysis
RNA was quantified using a Nanodrop and cDNA amplification was performed using
Bio-Rad iTaq Universal SYBR® Green One-Step Kit. Data analysis was performed using a BioRad Single Color Real Time PCR detection system (Bio-Rad Laboratories, Hercules, CA). The
following primers were synthesized by Invitrogen Life Technologies (Grand Island, NY): RAGE
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(For-CCC TTA GCT GGC ACT TAG ATG G and Rev-TGA CCG CAG TGT AAA GAG TCC
C), Gas6 (For-GAG TGC CGT GAT TCT GGT C and Rev-CCA CTA AGG AAA CAA TAA
CTG) and β-actin (For-ACA GGA TGC AGA AGG AGA TTA C and Rev- CAC AGA GTA
CTT GCG CTC AGG A).
Multiplex Cytokine Secretion Assessment
BALF collected at the time of necropsy was used to screen inflammatory mediators. Equal
amounts of protein were used for cytokine and chemokine quantification using a LuminexMagpix
multiplexing platform (Luminex Corporation, Austin, TX). Quantification of cytokine/chemokine
concentrations in the serum samples was specifically performed using a mouse cytokine/chemokine 27‐
plex bead panel (Millipore Corporation, Billerica, MA). Procedures were performed as suggested by the
manufacturer. Briefly, antibody‐conjugated magnetic beads were incubated with cell serum samples in a
96‐well followed by sequential incubations with biotinylated detection antibody and streptavidin‐
phycoerythrin. Bead complexes were then read on the Magpix multiplex platform (Luminex
Corporation). Standardcurves and data analysis were performed using Milliplex Analyst 5.1 software
(Millipore Corporation).
Statistical Analysis
Data are shown as mean ± SE. Differences between groups were determined using
Kruskal-Wallis tests, with P < 0.05 considered significant.
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Results
RAGE Expression Following SHS
Quantitative RT-PCR analysis revealed elevated RAGE expression following SHS
exposure when compared to room-air (RA) controls (Figure A.1A). Protein expression was
assessed by immunoblotting to confirm correspondence between transcriptional and translational
control. There was an equally robust induction of RAGE protein expression observed in SHSexposed mice compared to controls (Figure A.1B). Qualitatively, immunofluorescent staining
showed diffuse RAGE expression in airways and lung parenchyma (Figure A.1C).
Administrationof SAGEs significantly inhibited SHS-induced RAGE mRNA (Figure A.1A),
total protein (Figure A.1B), and spatial localization of RAGE (Figure A.1C).
AXL and Gas6 Expression Following SHS
Following SHS exposure, total AXL protein was significantly decreased compared to RA
exposed animals (Figure A.2A). Interestingly, when SAGEs that ameliorate RAGE signaling
were administered, AXL protein expression in SHS-exposed mice was not different than the RA
controls (Figure A.2A). These observations were confirmed spatially wherein
immunofluorescent staining showed significantly decreased staining for AXL following SHS
exposure and a return to diffuse staining when SAGEs were co-administered (Figure A.2B).
Despite an observable decrease in total AXL abundance following SHS exposure (Figure A.2B),
the activated AXL receptor, pAXL, was significantly increased in the mouse lung following SHS
exposure (Figure A…3).
Having confirmed abrogation of total AXL yet markedly increased pAXL following SHS
exposure, we next sought to evaluate the expression of Gas6, the key ligand for AXL signaling.
Mice subjected to SHS exposure did not significantly alter Gas6 mRNA or protein expression
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(Figure A.4A and A.4B); however, when SHS-exposed mice were concomitantly administered
SAGEs, Gas6 transcription (Figure A.4A) and protein (Figure A.4B) were significantly
enhanced. This intriguing discovery in which RAGE targeting during SHS enhances Gas6
expression thatperpetuates AXL signaling was confirmed qualitatively by immunofluorescent
staining (Figure A.4C).
Markers of Inflammation
To assess inflammatory profiles, we conducted a series of experiments to initially
evaluate to what extent SHS modulates lung inflammation. Quantification of leukocytic cells in
bronchoalveolar lavage fluid (BALF) revealed an expected increase in total cell quantity and
PMN abundance following exposure of animals to SHS (Figure A.5A and A.5B). We discovered
that total cellular abundance and percentage of PMNs were significantly decreased when SAGEs
were co-administered to mice were exposed to SHS (Figure A.5A and A.5B). Evaluation of total
protein abundance in BALF samples was undertaken to indirectly assess vascular permeability
commonly observed in vessels that are active sites of leukocyte diapedesis. BALF protein was
observed to be markedly increased following exposure to SHS but such increases were abrogated
in SAGE-treated mice (Figure A.5C).
We next considered specific pro-inflammatory cytokines. Analysis of the mediators
secreted into BALF confirmed a marked increase in the expression of IL-1α when mice were
exposed to SHS (Figure A.6A). Increased inflammation mediated by IL-2 (Figure A.6B) and
TNF-α (Figure A.6C) was also observed following SHS treatment. Analysis of the other
inflammatory molecules in the panel resulted in levels that were undetectable or were not
significantly different. In each instance, the expression of these SHS-induced mediators was
decreased whenmice were co-treated with both SHS and SAGEs (Figures A.6A-C).
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RAGE and AXL Expression in an In Vitro Model of Alveolar Epithelium
Due to the discovery that SHS differentially regulated RAGE and AXL expression and
that RAGE targeting by SAGEs further impacted the expression of both receptors (Figures A.1
and A.2), we sought to understand the dynamics of both receptors in the context of Gas6. We
therefore chose to characterize the two receptors in a cell culture model in which Gas6 was
administered. Immunoblotting revealed a significant increase in AXL protein expression
following Gas6 treatment and diminished AXL expression when co-cultured with R428 (Figure
A.7A). In addition, RAGE was significantly increased by alveolar epithelium following Gas6
treatment andRAGE protein expression was in similar fashion decreased when AXL signaling
was inhibited by R428 (Figure A.7B).
Discussion
Consequences of smoke exposure has a long history involving compromise of the
respiratory system. Such compromise is underpinned by debilitating, chronic inflammation that
hinders respiratory success and lung remodeling. The primary lung disorder that results from
tobacco smoke exposure is COPD, a heterogenous inflammatory disorder characterized by
airflow obstruction and irreversible tissue loss. It has become increasingly clear that innate
immune programs respond to inhaled agents and variable signaling pathways orchestrate basic
disease pathogenesis (Brusselle, Joos, & Bracke, 2011). Such inflammatory networks are
initiated by mediators that work with the innate immune system to detect inhaled particulates.
Through receptor signaling mechanisms, pathways recruit inflammatory modulators in order to
attempt the reversal of the dangers of particulates or the endogenous particles released during
sustained tissue damage. The current work sought to understand two such signaling initiators: the
pattern recognition receptor RAGE and the inflammatory axis controlled by AXL. With
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approximately 1 billion people exposed to smoke worldwide, the societal and economic burden
of exposure is profound (Courtney, 2015). This excessive burden is primarily driven by the cost
of acute exacerbations, which are acute or sub-acute physiologic deterioration in airways
function, inflammatory in nature, that lead to more than 1.5 million emergency room visits and
700,000 hospitalizations each year (Ford, 2015; Ford et al., 2013). Recovery from exacerbations
can be slow (Seemungal, Donaldson, Bhowmik, Jeffries, & Wedzicha, 2000), with only 75% of
patients recovering to baseline lung function at one month (Seemungal et al., 2000).
Exacerbations of COPD are also inducers of bad outcome. The 30-day all-cause risk of
readmission and death after hospitalization for a COPD exacerbation are 20% (Sjoding & Cooke,
2014) and 9% (Lindenauer et al., 2013), respectively, but risk is even greater longer term. It is
accordingly critical that greater understanding of inflammatory signaling programs be obtained.
We discovered enhanced RAGE expression in the lungs of mice after 4 weeks of SHS, which
supports previous data obtained by ourselves and others (Carp & Janoff, 1978; Chen L, 2014;
Joshua B. Lewis et al., 2017; Reynolds et al., 2008; Reynolds, Stogsdill, Stogsdill, & Heimann,
2011; Robinson et al., 2012). The current undertaking expands the field of smoke exposure
research by also demonstrating the abrogation of total AXL in the exposed lung. To date,
research involving both AXL and smoking has primarily implicated the receptor in downstream
gene regulation programs via methylation (Gao, Liu, et al., 2018; Gao, Urman, et al., 2018). Our
discovery that total AXL is diminished in a mouse model of SHS exposure, and subsequent
finding that RAGE inhibition via SAGEs leads to increased total AXL expression may shed light
into the relatedness of both receptors and the plausibility that AXL may have greater function
when RAGE is impaired. There is a clear impetus for expanded research into the biology of
pulmonary AXL signaling during SHS exposure as our data intriguingly revealedabundant
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activated AXL (pAXL, Figure A.3) following SHS exposure despite lower total AXL expression
(Figure A.2). Such an undertaking would also add context to our finding that Gas6 wasmarkedly
increased in lungs exposed to SHS while being administered the RAGE blocker SAGEs. Greater
Gas6 availability in such a scenario may involve the cooperation of additional receptor tyrosine
kinases such as Tyro and Mer, which also bind Gas6 to initiate signaling (Korshunov, 2012;
Laurance, Lemarié, & Blostein, 2012). While Gas6 has highest affinity for AXL, all three
receptors may have novel functions in the smoke exposed lung that remain unknown. Despite the
need for additional detail, it remains clear that RAGE and AXL are not independent, rather a
relatedness exists between both signaling receptors (Figures A.1-4).
Our research of BALF revealed characteristics previously observed during inflammatory
lung conditions. Elevated BALF protein suggests augmented vascular permeability, which has
been associated with airway inflammation (Higaki et al., 2015). Our finding that leukocyte
diapedesis was enhanced in SHS-exposed mice, yet significantly diminished in mice that were
administered SAGEs, reinforced prior research that demonstrated increased cellular recruitment
into the airways of mice and patients exposed to tobacco smoke (Awji, Seagrave, & Tesfaigzi,
2015; Wang et al., 2017). Inflammation modulating molecules were also differentially expressed
in the lungs of mice exposed to SHS. Expression of IL-1α, TNF-α and IL-2 were all significantly
increased in SHS-exposed mice and returned to basal expression in the animals administered
SAGEs. IL-1α is a pro-inflammatory member of the IL-1 family that plays a role in both the
innate and adaptive immune responses (Dinarello, 2009). With the precursor and cleaved
isoforms both being active, elevated IL-1α has been detected in COPD patients and in mouse
models of COPD (Botelho et al., 2011; Pauwels et al., 2011). TNF-α elaboration is associated
with down-stream mediators that are released following its secretion including IL-1α,IL-1β, IL-6,
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and ROS (Laskin et al., 2010). Secretion of TNF-α is increased in mouse models oftissue injury
(Pendino, Shuler, Laskin, & Laskin, 1994) and in several models of lung inflammation (Strzelak,
Ratajczak, Adamiec, & Feleszko, 2018). Because TNF-α, IL-1α, and IL-1β cooperate in the
modulation of leukocyte migration, the cytokine quantities we’ve observed may explain the cell
counts detected in the exposed mice. We also saw increased SHS-mediatedexpression of IL-2.
IL-2 is a key regulator of inflammation in the COPD lung, with known functions in coordinating
receptor availability and epithelial cell repair (Crosby & Waters, 2010;Ju, Sharma, Gaskin, & Fu,
2012). Taken together, data obtained from these BALF experiments and prevalent published
reports suggest that lung inflammatory responses to SHS are molecularly controlled.
We conducted in vitro analyses in order to coordinate RAGE and AXL expression. Given
the differential expression programs of RAGE, AXL, and Gas6 during SHS exposure, an
understanding of how Gas6 may impact the receptor’s expression was contemplated. We found
that Gas6, the key ligand for AXL, significantly increased the expression of both RAGE and
AXL. Furthermore, cell culture studies involving R428, an inhibitor of AXL signaling, revealed
that AXL abrogation diminished Gas6-induced RAGE and AXL expression. While these in vitro
experiments clearly show inducibility of the receptors in the context of Gas6/AXL, our complete
set of data involving inhibitors of RAGE (SAGEs) and AXL (R428) implicates a link between
both receptors that was previously unknown. Follow up research should focus on additive and/or
compensatory aspects of both RAGE and AXL in the fine tuning of smoke-mediated lung
inflammation. Such an undertaking would clarify a possible model in which SHS induces
RAGE and pAXL during inflammatory responses (Figure A.8). Exploration of this model with
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an emphasis on intervention may ameliorate the acute exacerbations of exposure and in
turn, dampen the debilitating effects of acute COPD episodes that require immediate
medical intercession.

123

Abbreviations
ATI (II)

Alveolar type I (or II) cell

AXL

AXL receptor kinase

BALF

Bronchoalveolar lavage fluid

COPD

Chronic obstructive pulmonary disease

CSE

Cigarette smoke extract

FAMRI

Flight Attendant’s Medical Research Institute

HMGB-1

High mobility box protein 1

IACUC

Institutional animal care and use committee

IL-1a

Interleukin 1 alpha

IL-2

Interleukin 2

LPS

Lipopolysaccharide

pAXL

Phosphorylated AXL receptor kinase

RA

Room air

RAGE

Receptors for advanced glycation end-products

ROS

Reactive oxygen species

SAGEs

Semi-synthetic glycosaminoglycan ethers

SHS

Secondhand smoke
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Figure A.1: RAGE mRNA and Protein Expression with SHS Exposure.
A, RAGE mRNA expression was elevated in lungs from mice following exposure to SHS. Exposure of
animals to SHS and SAGEs significantly decreased SHS-induced RAGE transcription. The mRNA was
normalized to β-actin (n = 6 mice per group) and representative data are shown with *p ≤ 0.05. B,
Analysis of RAGE protein demonstrated that animals exposed to SHS increased RAGE expression while
animals co-treated with SAGEs experienced less SHS-induced expression of RAGE. Blots were
densitometrically normalized to β-actin and ratios of RAGE/β-actin are presented with *p ≤ 0.05. C,
Immunofluorescence revealed abundant RAGE expression in small airways and lung parenchyma
following SHS exposure and markedly less RAGE expression when SAGEs were co-administered with
SHS. No primary controls revealed no immunoreactivity. Images (200x magnification) are representative
of experiments involving at least four animals from each group.
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Figure A.2: Total AXL Protein Expression in Response to SHS.
A, AXL expression was decreased in lungs from mice following exposure to SHS. Exposure of animalsto
SHS and SAGEs significantly increased SHS-mediated AXL back to RA levels. Blots were
densitometrically normalized to β-actin and ratios of AXL/β-actin are presented with *p ≤ 0.05. B,
Immunofluorescence revealed notably less AXL expression in the SHS-exposed lung when compared to
RA controls and abundant AXL expression when SAGEs were co-administered with SHS. No primary
controls revealed no immunoreactivity. Images (200x magnification) are representative of experiments
involving at least four animals from each group.
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Figure A.3: pAXL Protein Expression in Response to SHS.
Immunofluorescence revealed abundant activated pAXL expression in the SHS-exposed lung compared
to undetectable pAXL expression in RA controls. SHS exposure in animals in which RAGE was targeted
by SAGEs returned pAXL expression to undetectable levels. No primary controls revealed no
immunoreactivity. Images (200x magnification) are representative of experiments involving at least four
animals from each group.
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Figure A.4: Gas6 mRNA and Protein Expression in Response to SHS.
A, Gas6 mRNA expression was not significantly different when comparing RA controls and animals
exposed to SHS. Exposure of animals to SHS and SAGEs led to a highly significant increase in the
transcription of Gas6. The mRNA was normalized to β-actin (n = 6 mice per group) and representative
data are shown with *p ≤ 0.05. B, Immunoblotting for Gas6 revealed significantly Gas6 protein when
SHS and SAGEs were used when compared to either RA or SHS alone. C, Immunofluorescence
coincided with mRNA analysis in that RA controls and SHS-exposed mice had undetectable Gas6
expression but when RAGE was targeted by SAGEs, highly significant expression patterns for Gas6 were
evident. No primary controls revealed no immunoreactivity. Images (200x magnification) are
representative of experiments involving at least four animals from each group.
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Figure A.5: BALF and Cells with SHS Exposure.
A, Total cells in bronchoalveolar lavage fluid (BALF) were significantly increased in mice exposed to
SHS when compared to RA controls (n = 6 mice per group). There was significantly less SHS-induced
cellularity in BALF from mice co-administered SHS and SAGEs B, The percentage of
polymorphonuclear cells (PMNs) was significantly elevated in mice exposed to SHS compared to room
air controls and unchanged in SHS+SAGE exposed mice. C, Total BALF protein was assayed using the
BCA technique to demonstrate vascular permeability. Protein was significantly elevated in mice
following SHS exposure (n = 6 mice per group) and treatment with SAGEs significantly decreased SHSinduced protein leak. Significant differences are noted as *p ≤ 0.05.

Figure A.6: Inflammatory Cytokines in the Lung Following SHS Exposure.
A, Significantly more IL-1α was secreted into BALF by mice exposed to SHS when compared to RA
controls and SAGEs significantly decreased SHS-induced IL-1α secretion (n = 6 mice per group). B,
Significant increase of IL-2 secretion into BALF by mice exposed to SHS was observed when compared
to controls. SAGEs significantly decreased SHS-induced IL-2 secretion (n = 6 mice per group). C, TNF-α
was significantly increased in the BALF by mice exposed to SHS when compared to controls and TNF-α
elaboration was diminished when animals were co-administered SAGEs (n = 6 mice per group).
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Figure A.7: AXL and RAGE Expression Following Gas6 Administration.
A, Immunoblotting for AXL was conducted in A549 cells following exposure to Gas6 or Gas6 + R428
for 24 hours. A marked increase in AXL protein expression was detected when cells were exposed to
Gas6 and AXL and R428 co-treatment decreased Gas6-induced AXL expression. B, Immunoblotting for
RAGE was also conducted in A549 cells following exposure to Gas6 or Gas6 + R428 for 24 hours. A
marked increase in RAGE protein expression was detected in the presence of Gas6 and AXL targeting by
R428 decreased Gas6-induced RAGE expression. Blots performed in triplicate were densitometrically
normalized to β-actin and ratios are presented with *p ≤ 0.05.
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Figure A.8: Proposed Model for SHS Induced Alteration in RAGE and AXL Expression.
Downstream effects of exposure include diminished AXL expression but highly significant pAXL
expression and markers of cellular inflammation.
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Abstract
Electronic cigarettes have given rise to a new, largely unregulated market within the
smoking industry. While generally supposed to be less harmful than traditional tobacco smoke,
awareness of the toxicity of electronic cigarette liquid is still scarce. Our objective was to
determine the impact of electronic cigarette flavoring and nicotine on gingival squamous cell
carcinoma invasion, RAGE expression and the elaboration of pro-inflammatory molecules.
Gingival and tongue squamous cell carcinoma cells were exposed to Red Hot or Green
Apple flavored electronic cigarette flavoring with or without nicotine. Immunofluorescence
determined RAGE expression. Real time cellular invasion was assessed using a RTCA DP
instrument. Culture medium was assayed for cytokine secretion. Compared to controls we
observed: increased cell invasion in gingival cells with Red Hot electronic cigarette flavoring
and decreased cell invasion with Green Apple; decreased cell invasion in tongue cells treated
with Red Hot electronic cigarette flavoring and no differences in invasion with Green Apple;
flavor and nicotine dependent increases in RAGE expression; and differential expression of IL1α, IL-8, and MMP-13.
We conclude that electronic cigarette flavoring and nicotine orchestrate differential
regulation of oral squamous cell carcinoma cell invasion and inflammatory effects. This study
provides an important initial step in dissecting RAGE-mediated mechanisms of cancerous
invasion and molecular avenues employed by oral squamous cell carcinoma.

Keywords: RAGE, oral, carcinoma, eCig
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Introduction
Electronic Cigarette (eCig) use has increased dramatically during the last several years.
Numerous reports have sought to establish these products as safer to use than conventional
cigarettes.(Pisinger, Godtfredsen, & Bender, 2019; Pisinger & Mackay, 2019) The increased use
is further attributed to the notion that eCig prevents the adverse effects of combustible cigarettes
and may be pursued as a means that assists smokers in their cessation efforts.(Alzahrani, Pena,
Temesgen, & Glantz, 2018) eCigs are hand-held electronic devices that generate vapors or
aerosols from e-cigarette liquid (eCig liquid) without combustion.(Chen, Todd, & Fairclough,
2019) eCig liquid usually contains a mixture of propylene glycol, glycerin, nicotine and
flavors.(Alzahrani et al., 2018; Uchiyama et al., 2016) Although they are increasing in their
popularity, the World Health organization (WHO) regard the use of eCigs as harmful and does
not recommend their ongoing use.(Chen et al., 2019; Pisinger et al., 2019; Pisinger & Mackay,
2019) Previous experimental results showed that eCigs with flavorings caused increased
oxidative/carbonyl stress, increased inflammatory cytokine release, increase receptor for
advanced glycation end products (RAGE) expression, and increased apoptosis in human gingival
cells.(Rouabhia et al., 2017; Sundar, Javed, Romanos, & Rahman, 2016)
The receptor for advanced glycation end‐products (RAGE) is a pattern‐recognition cell‐
surface receptor that experiences increased expression during exposure to tobacco
smoke.(Chapman et al., 2018; Robinson, Stogsdill, Lewis, Wood, & Reynolds, 2012; Winden et
al., 2014) Expression of RAGE has been detected in gingival tissues from human subjects with
chronic periodontitis and it is overexpressed in gingival tissues from smokers diagnosed with
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periodontal diseases.(Chapman et al., 2018) RAGE receptor availability is implicated in the
pathogenesis of many inflammatory diseases and more recently, it’s been shown to be involved
in the invasion of oral squamous cell carcinoma (OSCC) (Bhawal et al., 2005; Chapman et al.,
2018).
In the current research endeavor, we examined the effects of two common eCig flavors,
sweet apple and cinnamaldehyde, with or without nicotine, on OSCC invasiveness and the effect
of exposure on RAGE expression. We also tested the inflammatory profiles of exposure via the
assessment of elaborated mediators into cell culture media. OSCC encompasses up to 90% of all
oral cancers and affects more than 400 000 individuals yearly (Chapman et al., 2018). OSCC is
one of the most prevalent cancers in developing countries with recurrence rates that approach
approximately 50%, and its progression is affected by environmental factors including cigarette
smoke and alcohol. (Bavle, Venugopal, Konda, Muniswamappa, & Makarla, 2016; Blatt et al.,
2017) Tobacco alone is well recognized as one of the major causes of the development of oral
cancer (Nagaraj & Zacharias, 2007) and work in our lab demonstrated that secondhand smoke
increases OSCC invasion in a RAGE dependent manner.(Chapman et al., 2018) The current
project expands the invasive attributes of OSCC by seeking to understand eCig-mediated
invasion and inflammation possibly orchestrated by the induction of RAGE.
Materials and Methods
Cell Culture and Treatments
Ca9-22 oral squamous carcinoma cells and CAL-27 human tongue squamous carcinoma
cells were used in these experiments (both from ATTC, Manassas, VA). Cells were cultured in
RPMI medium (Mediatech, Manassas, VA) supplemented with 10% fetal bovine serum (FBS)
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and 1% penicillin and streptomycin. Both cell lines were incubated for 24 hours in medium alone
(control), medium supplemented with 2% Cinnamon Red Hots (Red Hot, 8Ohm1, Inc., Ogden,
UT) or Reds Apple Juice (Green Apple, Daze Mfg., Los Angeles, CA) eCig liquid in the presence
or absence of 6mg of nicotine. A dose curve was pursued and a dose of 2% for both types of eCig
liquid exerted changes without affecting cell behavior (data not shown). For invasion studies,
cells were detached, and 20,000 cells/mL were incubated in 2% FBS mediumalone, or medium
supplemented with 2% eCig liquid in the presence or absence of nicotine.
Real-time Cell Invasion
Real-time cell invasion was determined following the various treatments. An
xCELLigence RTCA cell monitoring system was utilized to determine real time invasion
of cellsthrough adherence to the protocol suggested by the manufacturer (ACEA
Biosciences, Blue Springs, MO, USA). Briefly, invasion was assessed in 16 well CIMPlates (n= 10 individual cellcultures per treatment; ACEA Biosciences, Blue Springs,
MO, USA). The top wells were coatedwith a 1:40 matrigel concentration (Fisher
Scientific, Pittsburg, PA) and cells were plated in the top chamber at a concentration of
20,000 cells/well in 2% FBS RPMI with total volume of 100µL in the presence or
absence of eCig liquid in the presence or absence of nicotine. The bottom chamber wells
were filled with 160 µL of 10% FBS RPMI. The cells were then placed inthe
xCELLigence RTCA instrument and invasion readings were completed every 15 minutes
for24 hours. Invasive cells were obtained and expressed as cell invasion index.
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Immunofluorescence
Immunofluorescence (IF) was performed to determine the localization of RAGE
in treated and untreated cells. Slides were incubated overnight with antibody against
RAGE (Cell Signaling Technology, Danvers, MA, USA) or an immunoglobulin G1negative control (JacksonLaboratories, West Grove, PA). Slides were incubated with a
Texas red-conjugated secondary
for 1 h and then 4, 6-diamidino-2-phenylindole dihydrochloride (DAPI) for nuclear
counterstaining prior to mounting with glass coverslips. Slides were viewed with the
appropriateexcitation and emission rhodamine filter.
Periodontal Inflammatory Cytokine Assessment
Medium from treated and control cells were screened using the multiplex Human
Cytokine 17-plex Magnetic Bead Kit (EMD Millipore, Billerica, MA). The Milliplex
assay was performed as previously described19. Beads and the appropriate detection
antibodies are includedin the Milliplex Multiplex Assay kit and were added to the control
or treated conditioned media. The samples were incubated with antibody-conjugated
magnetic beads overnight at 4°C. Bead- complexes were then read on a Magpix
multiplex platform (Luminex Corporation, Austin, TX). Median fluorescent values were
recorded from a minimum of 80 beads used in the data analysis.Standard curves and data
analysis were performed using Milliplex Analyst 5.1 software (Millipore Corporation,
Billerica, MA).
Statistical Analysis
Results were checked for normality and data were shown as means ± SE.
Differences in cell invasion and cytokine protein expression were determined between
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control and treated cells.Mann-Whitney tests were used to compare changes among the
cytokines and for differences in invasion indexes. Significant differences between groups
were noted at p < 0.05. Statistical analysis was completed with GraphPad Prism 7.0
software.
Results
E-Cig Liquid and OSCC Invasion
We first investigated the effects of eCig liquid on OSCC cell invasion. We
observed thatthe addition of 2% Green Apple eCig liquid significantly reduced cell
invasion (2.7-fold; p<0.0002) in Ca9-22 cells (Figure B.1A). The addition of nicotine to
the media resulted in some improvement (35%, 1.7-fold; p<0.0002) despite the overall
decrease in invasion observed in these cells when treated with 2% Green Apple liquid
alone (Figure B.1A). In contrast, treatment ofCa9-22cells with 2% Red Hot significantly
increased invasion (3.6-fold; p<0.0002). Interestingly, increased invasion mediated by
Red Hot was decreased (30%, 2.3-fold; p<0.0002)with the inclusion of nicotine to the 2%
Red Hot eCig liquid (Figure B.1B).
Treatment of CAL-27 tongue squamous cells with 2% Green Apple did not affect
cell invasion in either the presence or absence of nicotine (Figure B.2A). Unlike 2%
Green Apple, weobserved decreased cell invasion (1.44-fold; p<0.002) in the CAL-27
tongue squamous cells when treated with 2% Red Hot eCig liquid (Figure B.2B).
Decreased invasion was modestly reduced(7%,1.3-fold; p<0.002) when nicotine was
added to the 2% Red Hot treatment (Figure B.2B).
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RAGE and Cytokine Release
Previous studies by our lab showed a role for RAGE in mediating invasion and
inflammation of OSCC cells when exposed to smoke environments (Chapman et al.,
2018; Sanders et al., 2017). We therefore investigated the expression of RAGE during
eCig liquid treatment of Ca9-22 and CAL-27 carcinoma cells. Immunofluorescence
demonstrated increased RAGE staining in Ca9-22 OSCC cells treated with 2% Green
Apple or 2% Red Hot (Figure B.3A andB). This increase in RAGE expression was
potentiated when nicotine was added to either eCig liquid (Figure B.3A and B).
Similarly, RAGE staining was increased following treatment of CAL-27cells that was
further potentiated when nicotine was added (Figure B.4A and B).
Prior studies implicate RAGE signaling in the modulation of inflammation via
increased cytokine elaboration (Sanders et al., 2017). To determine to what extent
cytokine release was regulated by eCig treatment, we performed protein assays that
simultaneously screened key inflammatory cytokines observed during periodontal
disease. The concentration of IFN-γ, IL-1β,IL-12, IL-4, IL-6, IL-10, IL-12, IL-17, MIP1α, MMP-9, Osteoprotegerin, Osteopontin, Osteoactivin, RANK, TGFβ1 and TNFα
released into cell culture media was below the levels of detection; thus, we were not able
to accurately determine their concentrations in the media from either control or treated
cells. In the Ca9-22 cells, IL-1α was significantly increased (54- fold; p<0.02) when cells
were treated with 2% Green Apple when compared to controls (Figure B.5A). The
addition of nicotine to Green Apple treatment reduced the expression of this cytokine by
93% (3.4-fold increase; p<0.02, Figure B.5A). Treatment of Ca9-22 with 2% Red Hot
demonstrated a very significant increase (580-fold; p<0.02) of IL-1α when compared to
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controls (Figure B.5A). When nicotine was added to the 2% Red Hot media, the
increased IL-1α was reduced by 95% (28-fold; p<0.02, Figure B.5A). IL-8 secretion was
increased (2.2-fold; p<0.002) by treatingCa9-22 cells with 2% Green Apple alone (Figure
B.5B). In contrast, when nicotine was added to the cells in 2% Green Apple, IL-8 was
decreased (3.3-fold; p<0.002) when compared to controls (Figure B.5B). Interestingly IL8 secretion was below detection in the 2% Red Hot treated Ca9-22 cells (Figure B.5B).
MMP-13 levels were decreased by 2% Green Apple treatment (1.2-fold increase;p<0.03)
in Ca9-22 cells (Figure B.5C). When nicotine was added this small decrease was reversed
to basal levels observed in controls (Figure B.5C).
Treatment of the CAL-27 tongue squamous cells with 2% Green Apple showed
increased IL-1α (3.6-fold; p<0.02) when compared to controls (Figure B.5D). The
addition of nicotine to the 2%Green Apple did not affect IL-1α secretion levels by these
cells (3.8-fold; p<0.02). Similarly, treatment of CAL-27 cells with 2% Red Hot alone
increased IL-1α (17.8-fold; p<0.02) when compared to controls (Figure B.5D).
Interestingly, addition of nicotine reduced IL-1α levels by 52% (8.5-fold increase;
p<0.02) compared to the treatment of 2% Red Hot alone (Figure B.5D). IL-8 levelswere
mildly increased (1.1-fold; p<0.04) in CAL-27 cells that were treated with 2% Green
Apple and this increase was not affected when nicotine was added (Figure B.5E). When
CAL-27 cells were treated with 2% Red Hot, IL-8 levels were decreased (1.2-fold;
p<0.04) when compared to control cells (Figure B.5E). This decrease was potentiated
(3.2-fold; p<0.04) by the addition of nicotine (Figure B.5E). MMP-13 levels were
reduced when CAL-27 cells were treated with 2% GreenApple in the absence (2.7-fold;
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p<0.0001) or presence (2.9-fold; p< 0.001) of nicotine (Figure B.5F). Interestingly,
MMP-13 secretion was below the detection limit in the 2% Red Hot treated CAL-27 cells
(Figure B.5F).
Discussion
Although cigarette smoke is already among the top ten contributors to the
worldwide health burden, eCigs are a phenomenon that has emerged in the United States
during the last decade. Flavored eCig vaping is steadily rising and troubling trends for
eCig use suggest an astonishing 1 out of 10 current adolescents regularly vape.(Kong &
Krishnan-Sarin, 2017; Singhet al., 2016) While attempts to regulate eCig use are
underway (Deeming Tobacco Products To Be Subject to the Federal Food, 2016), the
World Health Organization has stated eCig vaping should not be recommended until its
true toxicity profile and potential ill health effects have been properly vetted (World
Health Organization, 2013). Such adverse health effects associated with eCig use include
bronchitis, mouth/throat irritation, headaches, nausea, airway obstruction, bronchospasm,
inflammation, and cardiovascular effects (elevated heart rate, blood pressure, andvessel
stiffness) (Aberle, Abtin, & Brown, 2013; Etter, 2010; Gennimata SA, 2014; Polosa et
al.,2014; Vansickel, Cobb, Weaver, & Eissenberg, 2010; Vardavas et al., 2012; Wang et
al., 2018).
To determine the effects of eCig liquid and nicotine in OSCC progression, cell
invasion was assessed in commonly studied OSCC cell lines. We measured invasion
during exposure to two popular eCig liquids: Cinnamon Red Hots (Red Hot) or Reds
Apple Juice (Green Apple) in the presence or absence of nicotine. In the Ca9-22 cells, we
observed that invasion was increasedwhen cells were treated with Red Hot alone. In
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contrast, cell invasion was decreased when cells were treated with Green Apple alone.
These results suggest a flavor dependent effect in the regulation of cell invasion. As
many use eCigs as an alternative means of nicotine exposure aside from traditional
smoking, an understanding of nicotine related effects is essential. The addition of nicotine
in the presence of Red Hot diminished the increased invasion observed in exposed cells.
This was unexpected as these results suggest that perhaps the addition of nicotine exerted
measurable protection of invasion in Ca9-22 cells treated with Red Hot. When nicotine
was added to the Green Apple Ca9-22 treated cells, we observed a near reversal in the
invasion index. Although these nicotine results were not capable of reversing invasion to
basal levels, these data suggest that nicotine is a key variable of eCig use that must be
further explored. Together these data suggest that different molecular means are plausibly
involved in the regulation of these cancerous cells that are dependent on flavoring and the
presence of nicotine.
In terms of the CAL-27 cells, we did not detect any effect in cell invasion when
cells were treated with Green Apple in the presence or absence of nicotine. This was an
unexpected difference compared to our observations of the Ca9-22 cells and perhaps this
discovery is related to the previous observation that CAL-27 cells are tongue squamous
cell carcinoma cells known to have non typical OSCC behaviors (Jiang et al., 2009). This
alternative response compared to Ca9-22 cells was also observed when Red Hot was
added to the CAL-27 cells. In this instance, invasion was decreased in the presence of
eCig liquid alone and significantly recovered when nicotine was added to the cells.
Previous studies in our lab has linked RAGE expression to both inflammation and the
regulation of invasion during exposure of OSCC to smoke environments (Chapman et al.,
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2018; Sanders et al., 2017). We observed detectible RAGE protein expression in both cell
types via immunofluorescence staining. Interestingly we observed increased stainingfor
RAGE with both eCig liquids in Ca9-22. This increase was further potentiated when
nicotinewas added into the treatment. These data suggest the likelihood that RAGE
correlates to pathways involved in the regulation of invasion in Ca9-22 cells. Similar
results were observed for the CAL-27 tongue cells. These results collectively suggest that
in both cell types, RAGE may be involved in alternative cell invasion indexes, dependent
on the cell type, during eCig treatment. We anticipate performing follow up studies that
target RAGE in order to elucidate to what extent RAGE availability modulates
invasiveness. RAGE signaling generally involves the activation of several MAP kinases
and the activation of NF-κB (Schmidt & Stern, 2001). To further determine RAGE
involvement in these cells, investigations must also be conducted that assess these
signaling intermediates as well as nuclear activation of NF-κB in treated cells as well as
controls.
We detected increased inflammatory cytokines such as IL-1α and IL-8 when Ca922 were treated with either of the eCig liquids. IL-1α and IL-1β are products of distinct
genes but are similar in their modulation of inflammation. Both bind the same receptor
and are upregulatedduring an inflammatory response. IL-8 is a heparin binding member
of the alpha, or CXC family of chemokines. In addition of pro-inflammatory effects, IL8 oligomerizes and binds G-proteincoupled receptors to enhance angiogenesis during
pathologies including cancer. The observed increases in both IL-1α and IL-8 were
reduced when nicotine was added in these cells. However, MMP-13 was decreased with
Apple Green treatment and not detectable in Red Hot treated Ca9-22 cells. MMPs,
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including MMP-13, are zinc and calcium dependent endopeptidasesthat degrade
extracellular matrix. MMP-13 specifically has been shown to degrade aggrecans and
diverse collagens while functioning during cell-matrix interactions. Cell-matrix
interactions are key during invasion. Together with the RAGE immunofluorescence,
differential cytokine elaboration suggests that RAGE expression may be involved in the
development of inflammationand less so during the regulation of invasion in Ca9-22
cells. Importantly, nicotine treatment seemed to have a marginally protective role for
inflammation created by both eCig liquids. This protective role of nicotine has been
observed in other diseases and it is suggested to be orchestrated by regulating cytokine
expression (Lakhan & Kirchgessner, 2011; Piao et al., 2009).To our knowledge, this
protection has not previously been shown during OSCC progression in humans. In the
CAL-27 cells, we observed increased IL-1α when cells were treated with both eCig
liquids. Interestingly, nicotine did not affect the levels of this cytokine in the Green Apple
treated cells. In contrast a significant decrease of IL-1α was observed in cells treated with
Red Hot. These results suggest a divergent signaling pathway may be initiated in these
cells in a flavor dependent manner; however, RAGE augmentation still suggests RAGE
participation. Furthermore, it seems that nicotine protection is also flavor dependent in
the CAL-27 cells. IL-8 was mildly increased during Green Apple treatment and was not
affected by nicotine addition. Incontrast, Red Hot induced a significant increase of IL-8
that was not reversed by the addition of nicotine. MMP-13 was decreased in these cells
treated with Green Apple and below the detectionlimit when cells were treated with Red
Hot.
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In general, our experiments suggest that different eCig flavors can alternatively
affect OSCCs making it difficult to determine specific effects and/or consequences of
eCig use. We demonstrate the plausibility that RAGE availability correlates with eCigmediated invasion and inflammation. Additional studies are critically needed to further
identify the relationship betweenRAGE signaling and the pathological behavior of OSCC
cells during exposure. Such studies should include RAGE targeting and downstream
effects in terms of both signaling intermediates and functional molecule elaboration. Such
an undertaking would clarify the molecular underpinning of exposing OSCC cells to
vaporized eCig liquids and resulting invasiveness and inflammatory signaling.
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Figure B.1: Ca9-22 Invasion with Exposure to Green Apple or Red Hot eCig Liquid.
The addition of 2% Green Apple eCig liquid (A) significantly reduced cell invasion in the Ca9-22 OSCC
cells. This reduction in invasiveness significantly improved with the addition of nicotine. The addition of
2% Red Hot significantly increased invasion of Ca9-22 cells (B). Increased invasion induced by the
flavoring alone was improved when nicotine was included in the Red Hot flavoring (B). Invasion
experiments were conducted with an n = 10 as outlined in the Methods section and statistically different
values are noted as *P < .05.

Figure B.2: CAL-27 Invasion with Exposure to Green Apple or Red Hot eCig Liquid.
Green Apple eCig liquid did not affect CAL-27 cell invasion regardless of the presence or absence of
nicotine (A). Red Hot eCig liquid reduced CAL-27 invasion which was mildly rescued with the addition
nicotine (B). Invasion experiments were conducted in triplicate as outlined in the Methods section and
statistically different values are noted as *P < .05.
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Figure B.3: RAGE Expression by Ca9-22 Cells Treated with eCig Liquid.
Cells exposed to Green Apple (A) or Red Hot (B) both increased RAGE expression. Increased RAGE
expression was further enhanced when nicotine was included with the eCig flavoring. Experiments were
conducted in triplicate and Images (200x original magnification) are representative of the conducted cell
culture experiments. Scale bars represent 100 µm.
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Figure B.4: RAGE Expression by CAL-27 Cells Treated with eCig Liquid.
Cells exposed to Green Apple (A) induced a moderate up-regulation of RAGE expression and CAL-27
cells exposed to Green Apple liquid plus nicotine expressed slightly more RAGE when compared to cells
exposed to eCig liquid alone. CAL-27 cells exposed to Red Hot expressed high levels of RAGE with
expression further increased when nicotine was added with the Red Hot eCig liquid (B). Experiments
were conducted in triplicate and Images (200x original magnification) are representative of the conducted
cell culture experiments. Scale bars represent 100 µm.
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Figure B.5: Expression of IL-1α, IL-8, and MMP-13 by Ca9-22 and CAL-27 Cells Treated with eCig
Liquid.
Ca9-22 (A, B, C) and CAL-27 (D, E, F) cells were treated as indicated and conditioned cell culture media
was screened for IL-1α(A and D), IL-8 B and E), and MMP-13 (C and F). Secreted protein
concentrations were obtained in quadruplicate and statistically different values are noted as *P < .05.
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Roseman Conference – 2nd Place Poster Presentation
Abby Bennett: RAGE Implications During DNA Double Strand
Breaks in Trophoblast Cells.
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